
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Expression of human A53T alpha-synuclein without endogenous rat alpha-synuclein fails to elicit Parkinson’s disease-related phenotypes in a novel humanized rat model - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="67D7157789B76D331C15770010C3852D.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="plosone">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334032/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="PLOS One">
<meta name="citation_title" content="Expression of human A53T alpha-synuclein without endogenous rat alpha-synuclein fails to elicit Parkinson’s disease-related phenotypes in a novel humanized rat model">
<meta name="citation_author" content="Nicole K Polinski">
<meta name="citation_author_institution" content="Research Programs, The Michael J. Fox Foundation for Parkinson’s Research, New York, New York, United States of America">
<meta name="citation_author" content="Jukka Puoliväli">
<meta name="citation_author_institution" content="Charles River Discovery Research Services, Charles River Laboratories, Kuopio, Finland">
<meta name="citation_author" content="Leena Rauhala">
<meta name="citation_author_institution" content="Charles River Discovery Research Services, Charles River Laboratories, Kuopio, Finland">
<meta name="citation_author" content="Taina-Kaisa Stenius">
<meta name="citation_author_institution" content="Charles River Discovery Research Services, Charles River Laboratories, Kuopio, Finland">
<meta name="citation_author" content="Timo Bragge">
<meta name="citation_author_institution" content="Charles River Discovery Research Services, Charles River Laboratories, Kuopio, Finland">
<meta name="citation_author" content="Teija Parkkari">
<meta name="citation_author_institution" content="Charles River Discovery Research Services, Charles River Laboratories, Kuopio, Finland">
<meta name="citation_author" content="Anna-Maija Penttinen">
<meta name="citation_author_institution" content="Charles River Discovery Research Services, Charles River Laboratories, Kuopio, Finland">
<meta name="citation_author" content="Yi Chen">
<meta name="citation_author_institution" content="Neurodegenerative Diseases Research Unit, Biogen, Cambridge, Massachusetts, United States of America">
<meta name="citation_author" content="Omar S Mabrouk">
<meta name="citation_author_institution" content="Neurodegenerative Diseases Research Unit, Biogen, Cambridge, Massachusetts, United States of America">
<meta name="citation_author" content="Kelly E Glajch">
<meta name="citation_author_institution" content="Neurodegenerative Diseases Research Unit, Biogen, Cambridge, Massachusetts, United States of America">
<meta name="citation_author" content="Warren D Hirst">
<meta name="citation_author_institution" content="Neurodegenerative Diseases Research Unit, Biogen, Cambridge, Massachusetts, United States of America">
<meta name="citation_author" content="Michael Perkinton">
<meta name="citation_author_institution" content="Neuroscience BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, United Kingdom">
<meta name="citation_author" content="Terina N Martinez">
<meta name="citation_author_institution" content="Research Programs, The Michael J. Fox Foundation for Parkinson’s Research, New York, New York, United States of America">
<meta name="citation_author" content="Mark A Frasier">
<meta name="citation_author_institution" content="Research Programs, The Michael J. Fox Foundation for Parkinson’s Research, New York, New York, United States of America">
<meta name="citation_publication_date" content="2025 Aug 8">
<meta name="citation_volume" content="20">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e0329823">
<meta name="citation_doi" content="10.1371/journal.pone.0329823">
<meta name="citation_pmid" content="40779487">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334032/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334032/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334032/pdf/pone.0329823.pdf">
<meta name="description" content="Alpha-synuclein (aSyn) is linked to Parkinson’s disease (PD) through SNCA genetic mutations, phosphorylated aSyn in Lewy bodies and Lewy neurites, and most recently through evidence of aSyn aggregation in patient spinal fluid using the aSyn seed ...">
<meta name="og:title" content="Expression of human A53T alpha-synuclein without endogenous rat alpha-synuclein fails to elicit Parkinson’s disease-related phenotypes in a novel humanized rat model">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Alpha-synuclein (aSyn) is linked to Parkinson’s disease (PD) through SNCA genetic mutations, phosphorylated aSyn in Lewy bodies and Lewy neurites, and most recently through evidence of aSyn aggregation in patient spinal fluid using the aSyn seed ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334032/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12334032">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1371/journal.pone.0329823"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/pone.0329823.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12334032%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12334032/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12334032/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334032/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-plosone.png" alt="PLOS One logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to PLOS One" title="Link to PLOS One" shape="default" href="https://doi.org/10.1371/journal.pone.0329823" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">PLoS One</button></div>. 2025 Aug 8;20(8):e0329823. doi: <a href="https://doi.org/10.1371/journal.pone.0329823" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0329823</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22PLoS%20One%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PLoS%20One%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Expression of human A53T alpha-synuclein without endogenous rat alpha-synuclein fails to elicit Parkinson’s disease-related phenotypes in a novel humanized rat model</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Polinski%20NK%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Nicole K Polinski</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Nicole K Polinski</span></h3>
<div class="p">
<sup>1</sup>Research Programs, The Michael J. Fox Foundation for Parkinson’s Research, New York, New York, United States of America</div>
<div>Methodology, Project administration, Writing – original draft, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Polinski%20NK%22%5BAuthor%5D" class="usa-link"><span class="name western">Nicole K Polinski</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Puoliv%C3%A4li%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Jukka Puoliväli</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Jukka Puoliväli</span></h3>
<div class="p">
<sup>2</sup>Charles River Discovery Research Services, Charles River Laboratories, Kuopio, Finland</div>
<div>Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Puoliv%C3%A4li%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jukka Puoliväli</span></a>
</div>
</div>
<sup>2,</sup><sup>¤a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rauhala%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Leena Rauhala</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Leena Rauhala</span></h3>
<div class="p">
<sup>2</sup>Charles River Discovery Research Services, Charles River Laboratories, Kuopio, Finland</div>
<div>Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rauhala%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Leena Rauhala</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stenius%20TK%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Taina-Kaisa Stenius</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Taina-Kaisa Stenius</span></h3>
<div class="p">
<sup>2</sup>Charles River Discovery Research Services, Charles River Laboratories, Kuopio, Finland</div>
<div>Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stenius%20TK%22%5BAuthor%5D" class="usa-link"><span class="name western">Taina-Kaisa Stenius</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bragge%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Timo Bragge</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Timo Bragge</span></h3>
<div class="p">
<sup>2</sup>Charles River Discovery Research Services, Charles River Laboratories, Kuopio, Finland</div>
<div>Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bragge%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Timo Bragge</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Parkkari%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Teija Parkkari</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Teija Parkkari</span></h3>
<div class="p">
<sup>2</sup>Charles River Discovery Research Services, Charles River Laboratories, Kuopio, Finland</div>
<div>Project administration, Supervision</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Parkkari%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Teija Parkkari</span></a>
</div>
</div>
<sup>2,</sup><sup>¤b</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Penttinen%20AM%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Anna-Maija Penttinen</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Anna-Maija Penttinen</span></h3>
<div class="p">
<sup>2</sup>Charles River Discovery Research Services, Charles River Laboratories, Kuopio, Finland</div>
<div>Funding acquisition, Project administration, Supervision</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Penttinen%20AM%22%5BAuthor%5D" class="usa-link"><span class="name western">Anna-Maija Penttinen</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Yi Chen</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Yi Chen</span></h3>
<div class="p">
<sup>3</sup>Neurodegenerative Diseases Research Unit, Biogen, Cambridge, Massachusetts, United States of America</div>
<div>Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yi Chen</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mabrouk%20OS%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Omar S Mabrouk</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Omar S Mabrouk</span></h3>
<div class="p">
<sup>3</sup>Neurodegenerative Diseases Research Unit, Biogen, Cambridge, Massachusetts, United States of America</div>
<div>Investigation, Supervision</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mabrouk%20OS%22%5BAuthor%5D" class="usa-link"><span class="name western">Omar S Mabrouk</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Glajch%20KE%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Kelly E Glajch</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Kelly E Glajch</span></h3>
<div class="p">
<sup>3</sup>Neurodegenerative Diseases Research Unit, Biogen, Cambridge, Massachusetts, United States of America</div>
<div>Supervision</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Glajch%20KE%22%5BAuthor%5D" class="usa-link"><span class="name western">Kelly E Glajch</span></a>
</div>
</div>
<sup>3,</sup><sup>¤c</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hirst%20WD%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Warren D Hirst</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Warren D Hirst</span></h3>
<div class="p">
<sup>3</sup>Neurodegenerative Diseases Research Unit, Biogen, Cambridge, Massachusetts, United States of America</div>
<div>Conceptualization, Funding acquisition, Methodology</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hirst%20WD%22%5BAuthor%5D" class="usa-link"><span class="name western">Warren D Hirst</span></a>
</div>
</div>
<sup>3,</sup><sup>¤d</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Perkinton%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Michael Perkinton</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Michael Perkinton</span></h3>
<div class="p">
<sup>4</sup>Neuroscience BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, United Kingdom</div>
<div>Conceptualization, Methodology</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Perkinton%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Michael Perkinton</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Martinez%20TN%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Terina N Martinez</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Terina N Martinez</span></h3>
<div class="p">
<sup>1</sup>Research Programs, The Michael J. Fox Foundation for Parkinson’s Research, New York, New York, United States of America</div>
<div>Conceptualization, Funding acquisition, Methodology</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Martinez%20TN%22%5BAuthor%5D" class="usa-link"><span class="name western">Terina N Martinez</span></a>
</div>
</div>
<sup>1,</sup><sup>¤e</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Frasier%20MA%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Mark A Frasier</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Mark A Frasier</span></h3>
<div class="p">
<sup>1</sup>Research Programs, The Michael J. Fox Foundation for Parkinson’s Research, New York, New York, United States of America</div>
<div>Supervision</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Frasier%20MA%22%5BAuthor%5D" class="usa-link"><span class="name western">Mark A Frasier</span></a>
</div>
</div>
<sup>1</sup>
</div>
<div class="cg p">Editor: <span class="name western">Quyen Hoang</span><sup>5</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff001">
<sup>1</sup>Research Programs, The Michael J. Fox Foundation for Parkinson’s Research, New York, New York, United States of America</div>
<div id="aff002">
<sup>2</sup>Charles River Discovery Research Services, Charles River Laboratories, Kuopio, Finland</div>
<div id="aff003">
<sup>3</sup>Neurodegenerative Diseases Research Unit, Biogen, Cambridge, Massachusetts, United States of America</div>
<div id="aff004">
<sup>4</sup>Neuroscience BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, United Kingdom</div>
<div id="edit1">
<sup>5</sup>Indiana University, UNITED STATES OF AMERICA</div>
<div class="author-notes p">
<div class="fn" id="cor001">
<sup>✉</sup><p class="display-inline">* E-mail: <span>npolinski@michaeljfox.org</span></p>
</div>
<div class="fn" id="coi001"><p><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</p></div>
<div class="fn" id="currentaff001">
<sup>¤a</sup><p class="display-inline">Current address: Experimentica Ltd., Kuopio, Finland</p>
</div>
<div class="fn" id="currentaff002">
<sup>¤b</sup><p class="display-inline">Current address: Roche Pharma Research and Early Development (pRED), Roche, Basel, Switzerland</p>
</div>
<div class="fn" id="currentaff003">
<sup>¤c</sup><p class="display-inline">Current address: Takeda Pharmaceutical, Cambridge, Massachusetts, United States of America</p>
</div>
<div class="fn" id="currentaff004">
<sup>¤d</sup><p class="display-inline">Current address: DaCapo Brainscience, Cambridge, Massachusetts, United States of America</p>
</div>
<div class="fn" id="currentaff005">
<sup>¤e</sup><p class="display-inline">Current address: Critical Path Institute, Tuscon, Arizona, United States of America</p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Nicole K Polinski</span></strong>: <span class="role">Methodology, Project administration, Writing – original draft, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Jukka Puoliväli</span></strong>: <span class="role">Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Leena Rauhala</span></strong>: <span class="role">Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Taina-Kaisa Stenius</span></strong>: <span class="role">Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Timo Bragge</span></strong>: <span class="role">Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Teija Parkkari</span></strong>: <span class="role">Project administration, Supervision</span>
</div>
<div>
<strong class="contrib"><span class="name western">Anna-Maija Penttinen</span></strong>: <span class="role">Funding acquisition, Project administration, Supervision</span>
</div>
<div>
<strong class="contrib"><span class="name western">Yi Chen</span></strong>: <span class="role">Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Omar S Mabrouk</span></strong>: <span class="role">Investigation, Supervision</span>
</div>
<div>
<strong class="contrib"><span class="name western">Kelly E Glajch</span></strong>: <span class="role">Supervision</span>
</div>
<div>
<strong class="contrib"><span class="name western">Warren D Hirst</span></strong>: <span class="role">Conceptualization, Funding acquisition, Methodology</span>
</div>
<div>
<strong class="contrib"><span class="name western">Michael Perkinton</span></strong>: <span class="role">Conceptualization, Methodology</span>
</div>
<div>
<strong class="contrib"><span class="name western">Terina N Martinez</span></strong>: <span class="role">Conceptualization, Funding acquisition, Methodology</span>
</div>
<div>
<strong class="contrib"><span class="name western">Mark A Frasier</span></strong>: <span class="role">Supervision</span>
</div>
<div class="p">
<strong class="contrib"><span class="name western">Quyen Hoang</span></strong>: <span class="role">Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Jun 13; Accepted 2025 Jul 22; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 Polinski et al</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12334032  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40779487/" class="usa-link">40779487</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Alpha-synuclein (aSyn) is linked to Parkinson’s disease (PD) through <em>SNCA</em> genetic mutations, phosphorylated aSyn in Lewy bodies and Lewy neurites, and most recently through evidence of aSyn aggregation in patient spinal fluid using the aSyn seed amplification assay. Therefore, understanding the biology of this protein and developing therapeutic interventions targeting pathological processing of aSyn are a key area of focus for novel treatments to slow or stop PD. Reliable preclinical models are imperative for these efforts. To this end, we developed a novel model using CRISPR/Cas9 to humanize the regions surrounding the naturally occurring threonine 53 amino acid in the Sprague Dawley rat to generate a humanized A53T aSyn rat model (aSyn A53T KI). We also generated an <em>Snca</em> knockout (aSyn KO) line to pair with the humanized A53T aSyn rat line to confirm that phenotypes were not due to loss of endogenous rat aSyn protein. A systematic phenotyping study was performed on these lines, assessing PD-related pathology and phenotypes at multiple timepoints. The aSyn KO rat line was profiled at 6 and 12 months of age, revealing successful aSyn protein knockout. The aSyn A53T KI model was profiled at 4, 8, 12, and 18 months of age for motor and non-motor phenotypes, nigrostriatal degeneration, and brain pathology. We confirmed the aSyn A53T KI rat expresses human aSyn while lacking endogenous rat aSyn. Motor function and non-motor function remain largely unaffected in this model, and no overt nigrostriatal degeneration or brain pathology are observed up to 18 months of age. Although the aSyn A53T KI rat lacks the ability to model PD pathology and phenotypes at baseline, it is an ideal model for investigating the impact of exogenous synuclein aggregates or environmental triggers on human aSyn in an <em>in vivo</em> model system.</p></section><section id="sec001"><h2 class="pmc_sec_title">Introduction</h2>
<p>Parkinson’s disease (PD) is the second most common neurodegenerative disorder, currently affecting approximately 1% of the population but predicted to increase in the coming years with an aging population [<a href="#pone.0329823.ref001" class="usa-link" aria-describedby="pone.0329823.ref001">1</a>]. The vast majority of PD cases are sporadic, with no known genetic link. Among the known genetic links are mutations in the <em>SNCA</em> gene that encodes the protein alpha-synuclein (aSyn), including multiplications or point mutations, such as A53T, A30P, E46K, H50Q, and G51D [<a href="#pone.0329823.ref002" class="usa-link" aria-describedby="pone.0329823.ref002">2</a>–<a href="#pone.0329823.ref008" class="usa-link" aria-describedby="pone.0329823.ref008">8</a>]. The link between aSyn and PD is also observed in cases without <em>SNCA</em> mutations, as aSyn is a major component in the pathological hallmarks of PD – Lewy bodies and Lewy neurites [<a href="#pone.0329823.ref009" class="usa-link" aria-describedby="pone.0329823.ref009">9</a>].</p>
<p>Given the clear genetic and etiological links between <em>SNCA/</em>aSyn and PD, many preclinical models used to study PD biology and preclinical therapeutic development research employ genetic, expression, or pathogenic changes in aSyn to model disease pathology. For <em>in vivo</em> rodent models, these include the use of viral vectors to overexpress wild-type (WT) or A53T mutant human aSyn [<a href="#pone.0329823.ref010" class="usa-link" aria-describedby="pone.0329823.ref010">10</a>], injection of pre-formed aSyn fibrils (PFF) to seed pathology in the endogenous protein [<a href="#pone.0329823.ref011" class="usa-link" aria-describedby="pone.0329823.ref011">11</a>], and transgenic or bacterial artificial chromosome (BAC)-transgenic overexpression of WT or mutant human aSyn [<a href="#pone.0329823.ref012" class="usa-link" aria-describedby="pone.0329823.ref012">12</a>,<a href="#pone.0329823.ref013" class="usa-link" aria-describedby="pone.0329823.ref013">13</a>]. These different model systems each have their benefits and limitations with regards to modeling PD pathology/phenotypes, construct validity, and practicality [<a href="#pone.0329823.ref014" class="usa-link" aria-describedby="pone.0329823.ref014">14</a>].</p>
<p>Briefly, the viral vector-based overexpression model induces nigrostriatal degeneration and behavioral phenotypes within a relatively quick time frame, but the reliance on high levels of aSyn overexpression to drive this pathology limits its relevance to the patient condition [<a href="#pone.0329823.ref015" class="usa-link" aria-describedby="pone.0329823.ref015">15</a>]. For the aSyn PFF model, dysfunction occurs as a result of pathology in endogenous aSyn without the need for supraphysiological levels of aSyn expression, which makes the pathogenic mechanism of this model more similar to what is seen in the patient condition. However, pathology in the model is heavily dependent on difficult aSyn PFF preparation and quality control steps, motor phenotypes of this model are not robust, and the long time frames needed for only moderate nigrostriatal degeneration can limit practicality [<a href="#pone.0329823.ref011" class="usa-link" aria-describedby="pone.0329823.ref011">11</a>,<a href="#pone.0329823.ref015" class="usa-link" aria-describedby="pone.0329823.ref015">15</a>]. Transgenic models benefit from having constitutive expression of human aSyn throughout the brain and other tissues, which enables modeling of the extra-nigral pathology and non-motor symptoms. Furthermore, transgenic models are more accessible as they do not require additional handling and intraparenchymal injections of viruses or PFFs. However, the drawback of these models is that the nigrostriatal system generally remains intact, phenotypes vary greatly based on the expression method and levels, and endogenous WT rodent aSyn is also present in most cases [<a href="#pone.0329823.ref012" class="usa-link" aria-describedby="pone.0329823.ref012">12</a>].</p>
<p>Recent efforts aimed to refine aSyn transgenic models to address some of these inherent drawbacks. This is important, as improved models with nigrostriatal and extranigral aSyn pathology and neurodegeneration in PD-relevant brain systems that result in motor and non-motor PD behavioral phenotypes would enable better translational modeling of PD biology and pathology. Such models would help to identify reliable PD biomarkers and develop novel therapeutics directed towards aSyn and its associated pathological mechanisms. Furthermore, expression of the human aSyn in the absence of the rodent homologous protein would enable more accurate testing of the many aSyn-targeting therapies—typically targeting human aSyn and not rodent aSyn—in a translational preclinical model <em>in vivo</em>. One of the first models attempting this was the SNCA-OVX model generated by the Wade-Martins lab that used BAC transgenic technology to express the complete human <em>SNCA</em> locus for near-physiological expression of human aSyn in mice lacking endogenous mouse aSyn protein [<a href="#pone.0329823.ref016" class="usa-link" aria-describedby="pone.0329823.ref016">16</a>]. Although this model does display striatal dopamine signaling deficits followed by nigral neuron loss and motor dysfunction, it lacks aSyn aggregation and phosphorylation at S129 in the substantia nigra, and aSyn is expressed at ~2-fold greater than endogenous levels [<a href="#pone.0329823.ref016" class="usa-link" aria-describedby="pone.0329823.ref016">16</a>]. More recently, a novel gene replacement technology was developed and used to replace the mouse <em>Snca</em> with 158kb of the human <em>SNCA</em> gene [<a href="#pone.0329823.ref017" class="usa-link" aria-describedby="pone.0329823.ref017">17</a>]. However, this model has not yet been phenotypically analyzed to evaluate the impact of the gene replacement on PD pathology and phenotypes.</p>
<p>Herein, we describe the generation and characterization of a novel Sprague Dawley rat line in which endogenous rat <em>Snca</em> gene was humanized using the CRISPR/Cas9 technology. This strategy was pursued to determine whether humanizing the amino acids surrounding the naturally occurring threonine at amino acid 53 in rat would result in PD-like pathology similar to what is seen in cases with the A53T mutation in humans. As this humanization prevented the expression of endogenous rat aSyn, we also created a separate aSyn knockout rat on the Sprague Dawley background through the introduction of a point mutation that generated a premature stop codon to determine whether any phenotypes in the humanized aSyn knock-in model were related to the loss of endogenous rat aSyn or introduction of humanized A53T aSyn. Homozygous knock-in rats were phenotyped with littermate controls across multiple time points, and their motor and non-motor phenotypes, nigrostriatal degeneration, synuclein pathology, and additional pathology markers were analyzed.</p></section><section id="sec002"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="sec003"><h3 class="pmc_sec_title">Rat model generation</h3>
<p>Two new rat lines were generated at SAGE Labs, Inc. (St. Louis, MO, USA) for this study. The first line is a humanized A53T aSyn rat on the Sprague Dawley background, in which CRISPR-Cas9 strategies were used to target the <em>Snca</em> region encoding amino acids 67–140 of aSyn which contains 6 amino acid differences, retaining the endogenous rat threonine at amino acid 53. To humanize 6 amino acid differences (specifically N87S, M100L, G103N, Y107A, S121D, and S122N) CRISPR was used to replace <em>Snca</em> amino acids 67–140 with a human <em>SNCA</em> cDNA (<a href="#pone.0329823.s001" class="usa-link">S1 Fig</a>). This resulted in humanized A53T aSyn expression under the endogenous regulatory elements and promoter with a lack rat aSyn of expression. As a control, we also developed a rat aSyn KO line to ensure any phenotypes were not due to loss of endogenous rat aSyn. To generate this line, CRIPSR-Cas9 strategies were used in Sprague Dawley rats to insert a “T” base pair at position 17,446 in the genomic sequence of rat <em>Snca</em> to create a premature stop codon, which blocked rat aSyn protein expression. F1 heterozygous male and female rats of each line were bred to homozygosity at SAGE Labs. These lines are currently available to the research community through Taconic Biosciences (Rensselaer, NY, USA) as HsdSage:SD-<em>Snca</em><sup><em>em1(SNCA-A53T)Sage</em></sup> (22964, aSyn A53T KI) and HsdSage:SD-<em>Scna</em><sup><em>em1Sage</em></sup> (22966, aSyn KO).</p></section><section id="sec004"><h3 class="pmc_sec_title">Breeding</h3>
<p>All animal experiments were performed as specified in the license authorized by the National Animal Experiment Board of Finland (No. ESAVI/9296/04.10.07/2017) and according to the US National Institutes of Health (Bethesda, MD, USA) guidelines for the care and use of laboratory animals.</p>
<p>Animals used in this study were bred at Charles River Laboratories facility in Wilmington (MA, USA) to generate cohorts of homozygous rats with wild-type (WT) littermates. Two male homozygous aSyn KO and 3 male homozygous A53T aSyn KI rats were obtained from Horizon Discovery and bred with equal numbers of WT female Sprague Dawley rats from Horizon Discovery. This breeding scheme created a colony of heterozygous rats which were then bred to generate cohorts of homozygous, heterozygous, and WT littermates.</p>
<p>Homozygous and WT littermates were shipped to Charles River Discovery Research Services unit in Kuopio (Finland) at least 1 week before the experiments to allow for acclimatization. During the experiments, rats were housed in open top cages in a light-controlled environment (lights on at 07:00 am and off at 8:00 pm) at a temperature of 22 ± 1 °C and relative humidity of 40–70% with food (Teklad Global 2016, Envigo) and water provided <em>ad libitum</em>.</p></section><section id="sec005"><h3 class="pmc_sec_title">Experimental scheme: KI rats</h3>
<p>A cohort of 79 aSyn A53T KI rats (32 males and 47 females) and 82 WT littermates (34 males and 48 females) was used for the experiments elucidating effects of the A53T mutation. Animals were grouped according to age and genotype as described in <a href="#pone.0329823.t001" class="usa-link">Table 1</a>.</p>
<section class="tw xbox font-sm" id="pone.0329823.t001"><h4 class="obj_head">Table 1. Experimental groups of KI rats and their WT counterparts.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">Group</th>
<th align="left" colspan="2" rowspan="1">A53T KI</th>
<th align="left" colspan="2" rowspan="1">WT</th>
<th align="left" rowspan="2" colspan="1">Age at start (months)</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1">Male</th>
<th align="left" rowspan="1" colspan="1">Female</th>
<th align="left" rowspan="1" colspan="1">Male</th>
<th align="left" rowspan="1" colspan="1">Female</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">KI1</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">4</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">KI2</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">9*</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">4</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">KI3</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">KI4</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">10**</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">KI5</td>
<td align="left" rowspan="1" colspan="1">10**</td>
<td align="left" rowspan="1" colspan="1">10**</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">12</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">KI6</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">16</td>
<td align="left" rowspan="1" colspan="1">12</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">KI7</td>
<td align="left" rowspan="1" colspan="1">5**</td>
<td align="left" rowspan="1" colspan="1">15****</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">18</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">KI8</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">10****</td>
<td align="left" rowspan="1" colspan="1">12*****</td>
<td align="left" rowspan="1" colspan="1">18</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0329823.t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t001fn001"><p>Four animals were subsequently excluded from data analyses owing to unclear QuantiGene (see QuantiGene Plex assay sub-section below). Several animals had to be culled for health reasons before experiments were completed. These reasons did not appear linked to the genotypes given their nature (e.g., growths, bloody discharge from uterus, compromised breathing, weight loss) and the fact that these welfare issues occurred at similar rates in WT and SNCA A53T KI rats. Rats culled before endpoint sampling due to welfare reasons are denoted with asterisks (*).</p></div></div></section></section><section id="sec006"><h3 class="pmc_sec_title">Experimental scheme: KO rats</h3>
<p>A cohort of 10 male and 9 female aSyn KO rats, as well as 10 male and 10 female WT littermate control rats were used for the experiments to determine the effect of endogenous rat aSyn absence. Animals were grouped according to age and genotype as described in <a href="#pone.0329823.t002" class="usa-link">Table 2</a>.</p>
<section class="tw xbox font-sm" id="pone.0329823.t002"><h4 class="obj_head">Table 2. Experimental groups of KO rats and their WT counterparts.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">Group</th>
<th align="left" colspan="2" rowspan="1">aSyn KO</th>
<th align="left" colspan="2" rowspan="1">WT</th>
<th align="left" rowspan="2" colspan="1">Age at start (months)</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1">Male</th>
<th align="left" rowspan="1" colspan="1">Female</th>
<th align="left" rowspan="1" colspan="1">Male</th>
<th align="left" rowspan="1" colspan="1">Female</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">KO1</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">KO2</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">KO3</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">12</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">KO4</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">12</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0329823.t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec007"><h3 class="pmc_sec_title">Effects of A53T aSyn KI on rat behavior</h3>
<p>To establish how expression of the A53T-mutated humanized aSyn influences rat locomotor function, we performed a range of behavioral tests in separate groups of aSyn A53T KI and litter-matched WT animals aged 4, 8, 12, and 18 months (<a href="#pone.0329823.t001" class="usa-link">Table 1</a>).</p>
<section id="sec008"><h4 class="pmc_sec_title">Home cage activity.</h4>
<p>Rats were subcutaneously implanted with radio-frequency (RF) identification chips under isoflurane anesthesia before testing to unambiguously identify individual animals in their home cages, which were placed on top of the receiver plates (Actual Analytics Ltd, Edinburgh, UK). Transmitting RF chips and receiver plates allowed analysis of home cage behavior of rats, including measurements of activity and preferred location in the home cage over a 72 h monitoring period.</p></section><section id="sec009"><h4 class="pmc_sec_title">Open field.</h4>
<p>Spontaneous exploratory activity of aSyn A53T KI and WT littermate rats in the open field was examined using activity chambers (Med Associates, Inc., St Albans, VT, USA; 43.2 × 43.2 × 40 cm) equipped with infrared beams. Animals were tested in low-stress conditions with red light intensity lowered to approximately 10–30 lux. Rats were placed in the center of the chamber, and their behavior was recorded for 30 min and analyzed in 5 min intervals. Total distance moved, distance in the central area, average velocity, and rearing frequency were quantified.</p></section><section id="sec010"><h4 class="pmc_sec_title">Beam walk.</h4>
<p>Integrity of the sensorimotor function was assessed by analyzing how rats traverse a 160 cm horizontal tapered (square) beam that had underhanging ledges on each side to permit foot faults without falling [<a href="#pone.0329823.ref018" class="usa-link" aria-describedby="pone.0329823.ref018">18</a>]. A bright light was placed above the platform at the start point to motivate rats to traverse the beam. The end of the beam was connected to a black escape box (20.5 cm × 25 cm × 25 cm). Prior to the testing day, animals were pretrained to traverse the beam in three sessions over 3 preceding days. Rat beam walking was videotaped and the slip ratio (the number of slips/number of total steps) was calculated. Steps onto the ledge were scored as a slip. The mean of three successive trials was used for statistical analyses.</p></section><section id="sec011"><h4 class="pmc_sec_title">Fine motor skills and gait.</h4>
<p>A fully automated kinematic analysis system (MotoRater, TSE Systems GmbH, Bad Homburg, Germany) was used to analyze fine motor skills and gait of rats. The experimental set-up included a brightly illuminated Plexiglas corridor (153 × 5 × 10 cm) and a high-speed recording camera (300 fps) situated under that corridor [<a href="#pone.0329823.ref019" class="usa-link" aria-describedby="pone.0329823.ref019">19</a>]. MotoRater mirrors positioned at specific angles allowed simultaneous capture of rat movements from the left, right and ventral aspects by using Motion Capture and Analysis software (Simi Reality Motion Systems, Unterschleißheim, Germany). On the day of testing, the rats were marked in appropriate points of body, such as joints of limbs and parts of the tail, with a non-toxic paint to facilitate detection of movements. Rat locomotion parameters and gait characteristics were extracted from video recordings of five to six complete strides along the corridor. A stride was defined as movement between two consecutive left hindlimb floor contacts. Raw marker trajectory data were further analyzed using a custom analysis system. During the parameter determination procedure, the initial ground contacts and the onsets of the swing phases for each limb were detected first and then, strides were determined. The analyzed parameters included: 1) general gait pattern parameters (stride time and speed, step width, stance and swing time during a stride, interlimb coordination), 2) body posture and balance (toe clearance, iliac crest and hip height, hind limb protraction and retraction, tail position and movement), and 3) fine motor skills (swing speed during a stride, jerk metric during swing phase, angle ranges and deviations of different joints, vertical and horizontal head movement). Strides were excluded from analysis if the animal stopped for any reason, or if the stride was unusually slow (slower than 50% of the median speed). The correlation structure of the parameters was assessed using principal component analysis (PCA). An overall gait analysis score based on the differences in PC scores between aSyn A53T KI and WT rats was established and determined as described earlier [<a href="#pone.0329823.ref019" class="usa-link" aria-describedby="pone.0329823.ref019">19</a>]. The basis of the score was the discriminant vector that characterized effects of the A53T-mutated SNCA on gait parameters. The overall gait score for each rat was obtained by projecting normalized parameter data onto the discriminant vector.</p></section></section><section id="sec012"><h3 class="pmc_sec_title">Effect of A53T aSyn KI on gastrointestinal tract motility</h3>
<p>We assessed stool frequency on two successive days for 1 h each time. Each rat was removed from its home cage and placed in a clean, clear plastic cage without food or water for 1 h. Stools were collected immediately after expulsion and placed in sealed tubes. The total stools were weighed to provide a wet weight, then dried overnight at 65 °C and weighed again to provide a dry weight. In addition, number of stools was calculated.</p>
<p>For bead expulsion time measurements, rats were fasted for 12 h prior to the experiment. After that, a single 3 mm colored plastic bead was inserted under brief isoflurane anesthesia into the distal colon (3 cm past the anus) with a plastic rod. Animals were observed for 1 h to measure time until bead expulsion. If the bead was not expelled during the entire observation period, time of 60 min was used for statistical comparisons.</p></section><section id="sec013"><h3 class="pmc_sec_title">Endpoint sampling</h3>
<p>At the endpoint, rats were terminally anesthetized by pentobarbital (60 mg/kg, Mebunat, Orion Pharma, Espoo, Finland). Following cardiac puncture and terminal blood sampling, rats were transcardially perfused with heparinized saline.</p>
<section id="sec014"><h4 class="pmc_sec_title">Brain tissue collection.</h4>
<p>Right brain hemispheres of all aSyn KO rats and right brain hemispheres of half of aSyn A53T KI and litter-matched WT rats were dissected into the cortex, striatum, hippocampus, substantia nigra pars compacta (SNpc), and cerebellum for gene expression analyses. The right hemisphere samples, with the exception of the striatal samples in the aSyn KO (for HPLC; see below), of all aSyn KO, half of aSyn A53T KI, and their litter-matched WT rats, were collected as 5–10 mg punches, immersed in 5–10-fold greater volume of RNAlater, and stored at +4 °C overnight. Thereafter, RNAlater was removed and samples were stored at −80 °C until used for RNA transcript analyses using QuantiGene branched DNA (bDNA) technology (ThermoFisher Scientific, Waltham, MA, USA). Right striatum samples of all aSyn KO, half of aSyn A53T KI, and their litter-matched WT rats were weighed, fresh frozen in liquid nitrogen, and stored at −80 °C to be used for HPLC analysis.</p>
<p>Left brain hemisphere samples (cortex, striatum, hippocampus, substantia nigra pars compacta and cerebellum) from all aSyn KO rats, half of aSyn A53T KI rats, and their WT littermates were weighed, fresh frozen in liquid nitrogen, and stored at −80 °C to be used for western blotting. The left brain hemispheres of the remaining half of the aSyn A53T KI and litter-matched WT rats were dissected out in toto, post-fixed in 4% paraformaldehyde solution for 24 h, cryoprotected in a 30% sucrose solution in 0.1 M phosphate buffer (PB) for 72 h (until sunk), and frozen in liquid nitrogen for immunohistochemistry analysis.</p></section><section id="sec015"><h4 class="pmc_sec_title">Gut tissue collection.</h4>
<p>In half of the aSyn A53T KI and litter-matched WT rats, the gut was dissected out, and 3 cm samples of the duodenum (6 cm anal to the pyloric sphincter) and proximal colon (the first 6 cm distal to the cecum) were excised, cut open longitudinally, and carefully washed with phosphate buffer saline (PBS) to remove intestinal contents. Then, the samples were rolled into a package in the opposite direction to the intestinal structure (i.e., against the longitudinal axis) to form a roll-like structure. The package was tied with threads prior to fixation in 4% PFA in 0.1 M PB for a minimum of 24 h. The samples were then transferred to a 30% sucrose solution (in 0.1 M PB) at +4 °C for 48–72 h. After fixation and cryoprotection, the threads were removed, and the samples were frozen in liquid nitrogen and placed in foil on dry ice to maintain the original organ structure. The samples were stored at −80 °C until sectioning. Before sectioning, the collected duodenum and colon rolls were placed in separate Peel-A-Way® Disposable Embedding Molds (each sample from the same rat in its own mold) and embedded in Tissue-Tek Embedding Medium O.C.T. compound.</p></section></section><section id="sec016"><h3 class="pmc_sec_title">Immunohistochemistry</h3>
<section id="sec017"><h4 class="pmc_sec_title">Sectioning.</h4>
<p>The fixed, cryoprotected, and O.C.T.-embedded left hemisphere samples were sectioned with a cryostat in the coronal plane at an interval of 200 µm. In each cohort, the brains were cut into 6–8 full series of 20 µm thick cryosections, each containing representative sections of the cortex, striatum, hippocampus, SNpc, and cerebellum. Sections were collected on Superfrost glass slides using the following coordinates: slide A, 0.4 mm to −0.4 mm from bregma (striatum and cortex; five sections), slide B, −3.2 mm to −4.0 mm from bregma (hippocampus; five sections); slides C and D, −4.6 mm to −6.2 mm from bregma (SNpc; nine sections); and slide E: −9.2 mm to −10.0 mm from bregma (cerebellum; five sections).</p>
<p>Gut rolls were sectioned coronally (against the axis of the roll) with a cryostat. The duodenum and colon were sectioned separately into 20 µm thick cryosections. In total, three series at an interval of 200 µm were collected, with four sections per series. One series was used for the total aSyn staining, one for the phosphorylated aSyn staining, and one was reserved for piloting and negative controls.</p></section><section id="sec018"><h4 class="pmc_sec_title">Staining.</h4>
<p><em>TH staining and stereology:</em> Brain sections containing SNpc were stained for tyrosine hydroxylase (TH) and counterstained with cresyl fast violet as follows. Cryosections were air-dried for 30 min and washed three times with 1x PBS, pH 7.4. Endogenous peroxidase was blocked by incubating the sections in a 0.3% H<sub>2</sub>O<sub>2</sub> solution in methanol for 30 minutes. Then the sections were washed with a 0.3% solution of Triton X-100 in PBS (PBST; pH 7.4) and blocked with a 10% normal goat serum (NGS) solution in PBST for 30 min at room temperature. Sections were then washed with a 5% NGS solution in PBST for 5 min and incubated with the same solution containing a polyclonal rabbit antibody against TH (#AB152, Merck Millipore, Espoo, Finland) at 1:1000 dilution in 5% NGS solution in PBST overnight at room temperature. The following day, the sections were washed three times with PBS containing 5% NGS and incubated with the secondary biotinylated goat anti-rabbit antibody (Vector Laboratories, Inc., Newark, CA, USA) diluted 1:500 in the same solution for 2 h at room temperature. Then, the sections were washed three times with PBS containing 5% NGS and incubated with the avidin/biotin-based peroxidase system (Vector Laboratories, Inc., Newark, CA, USA) diluted in PBS (5 µL of reagent A + 5 µL of reagent B + 1,000 µL of PBS) for 120 min at room temperature. Sections were then washed three times with PBS, and chromogen was developed with ImmPact 3,3′-diaminobenzidine (Vector Laboratories, Inc., Newark, CA, USA) for 1 min, Visual examination until desired color was reached. The reaction was stopped by placing the sections in ddH2O three times.</p>
<p>Cresyl fast violet counterstaining was performed for 4 min, and the dye was washed with ddH<sub>2</sub>O twice for 90 s. Sections were treated with an increasing ethanol series of (70%, 95%, and 100%), cleared with Roticlear, mounted with Rotimount, and coverslipped for semiquantitative stereological analysis. The total numbers of TH-positive cells in the SNpc were estimated using the optical fractionator method [<a href="#pone.0329823.ref020" class="usa-link" aria-describedby="pone.0329823.ref020">20</a>]. The cells of interest were counted manually, with the region of interest for each section being separately delineated using Stereo Investigator 11 software (MicroBrightField, Williston, VT, USA). Usually, about 10 − 20 counting frames per section were analyzed. The Stereo Investigator 11 algorithm was used to take into account the region of interest area (ROI), number of counted TH-positive neurons, section thickness, and interval between the sections to calculate an estimation of the TH-total positive cell count within the ROI.</p>
<p><em>Phospho-Tau AT8 brain staining:</em> Brain cryosections were air-dried for 30 min and then washed three times with 1X TBS (pH 7.4). Antigen retrieval was performed in 1X Citrate buffer, pH 6.0 for 5 minutes at 80° C. Sections were washed once in 1X TBS (pH 7.4). Then, the sections were permeabilized using 0.3% Triton X-100 in TBS (pH 7.4) (TBST, pH 7.4), blocked with a 10% NGS solution in TBST for 30 min at room temperature. Sections were washed once with 5% NGS in TBST. Then, the sections were incubated overnight at room temperature with mouse monoclonal antibody against Phospho-Tau (Ser202, Thr205) Monoclonal Antibody (AT8) (MN1020, Thermo Fisher Scientific, Waltham, MA, USA) at 1:500 dilution in 5% NGS in TBST. The following day, sections were washed three times with 1X TBS (pH 7.4) and incubated in the secondary goat anti-mouse AF568 antibody (A21124, Molecular Probes, Eugene, Oregon, USA) diluted 1:500 in 5% NGS in 1x TBS for 2 h at room temperature. Then, the sections were washed three times with 1X TBS (pH 7.4), twice with double distilled H<sub>2</sub>O, twice with 70% EtOH and counterstained with 0.3% Sudan black B in 70% EtOH to quench autofluorescence. Finally, the sections were rinsed three times with 70% EtOH, washed three times in ddH2O, mounted, and coverslipped using ProLong Gold with DAPI. Positive control tissue from P301S tau transgenic mice was used to confirm staining success (<a href="#pone.0329823.s002" class="usa-link">S2A Fig</a>).</p>
<p><em>Iba-1 brain staining:</em> Brain cryosections were air-dried for 30 min and then washed once with 1X PBS (pH 7.4). Antigen retrieval was performed in 1X Citrate buffer, pH 6.0 for 5 minutes at 80° C. Sections were washed once in 1X PBS (pH 7.4). Then, the sections were permeabilized using PBST (pH 7.4) blocked with a 10% NGS solution in PBST for 30 min at room temperature. Sections were washed once with 1% NGS in PBST then incubated overnight at room temperature with rabbit polyclonal antibody against ionized calcium-binding adapter molecule1 (Iba-1,019-1974A, Fujifilm WAKO, Osaka, Japan) at 1:5000 dilution in 1% NGS in 1x PBST. The following day, sections were washed three times with PBST and incubated in the secondary goat anti-rabbit AF568 antibody (A11036, Molecular Probes, Eugene, Oregon, USA) diluted 1:500 in 1% NGS in 1x PBST for 2 h at room temperature. The sections were then washed three times with 1X PBS (pH 7.4), twice with double distilled H<sub>2</sub>O, twice with 70% EtOH and counterstained with 0.3% Sudan black B in 70% EtOH to quench autofluorescence. Finally, the sections were rinsed three times with 70% EtOH, washed three times in double distilled H<sub>2</sub>O, mounted, and coverslipped using ProLong Gold with DAPI.</p>
<p><em>GFAP brain staining:</em> Brain cryosections were air-dried for 30 min and then washed three times with 1X PBS (pH 7.4). Then, the sections were permeabilized using PBST (pH 7.4) blocked with a 10% NGS solution in PBST for 20 min at room temperature. Sections were washed once with 1% NGS in PBST. Then, the sections were incubated overnight at room temperature with rabbit polyclonal antibody against total glial fibrillary acidic protein (GFAP, #Z0334, Agilent DAKO, Santa Clara, CA, USA) at 1:5000 dilution in 1% NGS in PBST. The following day, sections were washed three times with 1X PBS (pH 7.4) and incubated in the secondary goat anti-rabbit AF568 antibody (A11036, Molecular Probes, Eugene, Oregon, USA) diluted 1:500 in 1% NGS in PBST for 2 h at room temperature. The sections were then washed three times with 1X PBS (pH 7.4), twice with ddH<sub>2</sub>O twice with 70% EtOH and counterstained with 0.3% Sudan black B in 70% EtOH to quench autofluorescence. Finally, the sections were rinsed three times with 70% EtOH, washed three times in ddH2O, mounted, and coverslipped using ProLong Gold with DAPI.</p>
<p><em>pS129 aSyn brain staining:</em> Brain cryosections were air-dried for 30 min and then washed three times with 1X TBS (pH 7.4). Then, the sections were permeabilized using PBST (pH 7.4) blocked with a 10% NGS solution in PBST for 30 min at room temperature. Sections were again washed with a 1% NGS solution in TBST for 5 min. The sections were then incubated overnight at room temperature with rabbit monoclonal primary antibody against phosphorylated (pS129) aSyn (#ab51253; Abcam, Cambridge, UK) at 1:500 dilution in 1% NGS in PBST. The following day, sections were washed three times with TBS (pH 7.4) and incubated in the secondary goat anti-rabbit AF568 antibody (A11036, Molecular Probes, Eugene, Oregon, USA) diluted 1:500 in 1% NGS in TBST for 2 h at room temperature. Then, the sections were washed three times with TBS (pH 7.4), twice with ddH<sub>2</sub>O twice with 70% EtOH and counterstained with 0.3% Sudan black B in 70% EtOH to quench autofluorescence. Finally, the sections were rinsed three times with 70% EtOH, washed three times in ddH2O, mounted, and coverslipped using ProLong Gold with DAPI. Positive control tissue from LRRK2 G2019S KI mice injected with an adeno-associated virus to overexpress human A53T aSyn was used to confirm staining success (<a href="#pone.0329823.s002" class="usa-link">S2B Fig</a>).</p>
<p><em>Total aSyn brain staining:</em> Brain cryosections were air-dried for 30 min and then washed three times with 1X TBS (pH 7.4). Then, the sections were permeabilized using PBST (pH 7.4) blocked with a 10% NGS solution in TBST (pH 7.4) for 20 min at room temperature. The sections were then incubated overnight at room temperature with rabbit polyclonal antibody against total aSyn (#2628S, Cell Signaling Technology, Beverly, MA, USA) 1:200 dilution in 1% NGS in 1x TBST. The following day, sections were washed three times with 1X TBS pH 7.4 and incubated in the secondary goat anti-rabbit AF568 antibody (A11036, Molecular Probes, Eugene, Oregon, USA) diluted 1:500 in 1% NGS in 1x PBST for 2 h at room temperature, Then, the sections were washed three times with 1X TBS pH 7.4, twice with 70% EtOH and counterstained with 0.3% Sudan black B in 70% ethanol to quench autofluorescence. Finally, the sections were rinsed three times with 70% EtOH, washed three times in ddH2O, mounted, and coverslipped using ProLong Gold with DAPI.</p>
<p><em>pS129 aSyn gut staining:</em> Gut cryosections were air-dried for 30 min and then washed three times with 1X TBS (pH 7.4). Then, the sections were permeabilized using PBST (pH 7.4) (TBST, pH 7.4) for 20 minutes blocked with a 10% NGS solution in PBST (pH 7.4) for 30 min at room temperature. Sections were again washed with a 1% NGS solution in PBST for 5 min. The sections were then incubated overnight at room temperature with rabbit monoclonal primary antibody against phosphorylated (pS129) aSyn (#ab51253; Abcam, Cambridge, UK) at 1:500 dilution in 1% NGS in 1x PBST. The following day, sections were washed three times with TBST and incubated in the secondary goat anti-rabbit AF568 antibody (A11036, Molecular Probes, Eugene, Oregon, USA) diluted 1:500 in 1% NGS in TBST for 2 h at room temperature, Then, the sections were washed three times with 1X TBS (pH 7.4), twice with 70% EtOH and counterstained with 0.3% Sudan black B in 70% ethanol to quench autofluorescence. Finally, the sections were rinsed three times with 70% EtOH, washed three times in ddH2O, mounted, and coverslipped using ProLong Gold with DAPI.</p>
<p><em>Total aSyn gut staining</em> Gut cryosections were air-dried for 45 min and then washed three times with 1X PBS (pH 7.4). Then, the sections were permeabilized using PBST (pH 7.4) blocked with a 10% NGS solution in PBST pH 7.4 for 45 min at room temperature. The sections were then incubated overnight at room temperature with rabbit polyclonal antibody against total aSyn (#2628S, Cell Signaling Technology, Beverly, MA, USA) 1:500 dilution in 1% NGS in 1x PBST. The following day, sections were washed three times with 1X PBS (pH 7.4) and incubated in the secondary goat anti-rabbit AF568 antibody (A11036, Molecular Probes, Eugene, Oregon, USA) diluted 1:500 in 1% NGS in 1x PBST for 2 h at room temperature, Then, the sections were washed three times with 1X PBS (pH 7.4), twice with 70% EtOH and counterstained with 0.3% Sudan black B in 70% ethanol to quench autofluorescence. Finally, the sections were rinsed three times with 70% EtOH, washed three times in ddH2O, mounted, and coverslipped using ProLong Gold with DAPI.</p></section></section><section id="sec019"><h3 class="pmc_sec_title">Expression of the endogenous rat <em>Snca</em> and A53T-mutated humanized <em>SNCA</em> genes</h3>
<section id="sec020"><h4 class="pmc_sec_title">Tissue processing for QuantiGene Plex assay.</h4>
<p>All punch biopsies of the cerebral cortex, striatum, hippocampus, substantia nigra, and cerebellum (approximately 5–10 mg total tissue weight each) were homogenized using the Working Homogenizing Solution prepared as per the manufacturer’s protocol in the QuantiGene Sample Processing Kit for Tissues (Thermo Fisher Scientific) as follows. After thawing, any excess RNAlater was carefully removed, and the tissue piece was homogenized using Ø5mm steel beads and a TissueLyser II device (Qiagen, Hilden, Germany). The homogenization volumes were adjusted to tissue weight (300 µL of the homogenizing solution + 3 µL of proteinase K per every 5 mg of tissue). The homogenates were incubated at 65°C for 30 min with mixing in between, after which the samples were centrifuged twice. The clear RNA-containing supernatants from the second step were collected and stored at −80°C in two aliquots, where possible, to avoid repeated freeze-thaw cycles.</p></section><section id="sec021"><h4 class="pmc_sec_title">QuantiGene Plex assay.</h4>
<p>Expression levels of the target genes were determined by the branched DNA assay using custom-prepared QuantiGene Plex sets and a QuantiGene Plex Assay Kit according to the manufacturer’s instructions (Thermo Fisher Scientific/Invitrogen). Small pilots were run before the actual assays to determine the optimal sample input: a 1:5–1:8 dilution of the original tissue lysate was ultimately used for all of the samples (depending on the tissue) to generate signals well above the limit of detection but not exceeding the linear range of the assay.</p>
<p>In aSyn KO rats and their WT littermates, expression levels of the endogenous <em>Snca</em> gene were examined in the cortex, hippocampus, cerebellum, and substantia nigra pars compacta. In aSyn A53T KI rats and their WT littermates, expression levels of the endogenous rat <em>Snca</em> gene and humanized A53T-mutated <em>SNCA</em> gene were determined in the cortex, striatum, hippocampus, cerebellum, and substantia nigra pars compacta. Signals associated with expression of endogenous rat <em>Snca</em> and humanized <em>SNCA</em> genes were normalized to the geometric mean of expression levels of three housekeeping genes (<em>Hmbs</em>, <em>Ppib</em>, and <em>Gapdh</em>). All targets analyzed in separate regions of the right brain hemisphere using the QuantiGene Plex assay are detailed in <a href="#pone.0329823.t003" class="usa-link">Table 3</a>.</p>
<section class="tw xbox font-sm" id="pone.0329823.t003"><h5 class="obj_head">Table 3. Genes for which mRNA expression levels were determined using the QuantiGene (bDNA) method.</h5>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">Target symbol</th>
<th align="left" rowspan="1" colspan="1">Target name</th>
<th align="left" rowspan="1" colspan="1">NCBI reference sequence</th>
<th align="left" rowspan="1" colspan="1">Samples</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Rat <em>Snca</em>, upstream, (MGC105443; bases 3–309)</td>
<td align="left" rowspan="1" colspan="1">Rat aSyn</td>
<td align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_019169" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_019169</a></td>
<td align="left" rowspan="1" colspan="1">KO, WT<sub>KO</sub>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Rat <em>Snca</em>, downstream, (MGC105443; bases 564–1082)*</td>
<td align="left" rowspan="1" colspan="1">Rat aSyn</td>
<td align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_019169" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_019169</a></td>
<td align="left" rowspan="1" colspan="1">KO, WT<sub>KO</sub><br>KI, WT<sub>KI</sub>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Human <em>SNCA</em> (bases 95–548)<sup>#</sup>
</td>
<td align="left" rowspan="1" colspan="1">Human aSyn KI</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000345" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000345</a> (custom probe set ID: GS03265)</td>
<td align="left" rowspan="1" colspan="1">KI, WT<sub>KI</sub>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>Hmbs</em>
</td>
<td align="left" rowspan="1" colspan="1">Rat hydroxymethylbilane synthase</td>
<td align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_013168" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_013168</a></td>
<td align="left" rowspan="1" colspan="1">KO, WT<sub>KO</sub><br>KI, WT<sub>KI</sub>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>Ppib</em>
</td>
<td align="left" rowspan="1" colspan="1">Rat peptidylprolyl isomerase B</td>
<td align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_022536" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_022536</a></td>
<td align="left" rowspan="1" colspan="1">KO, WT<sub>KO</sub><br>KI, WT<sub>KI</sub>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>Gapdh</em>
</td>
<td align="left" rowspan="1" colspan="1">Rat glyceraldehyde-3-phosphate dehydrogenase</td>
<td align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_017008" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_017008</a></td>
<td align="left" rowspan="1" colspan="1">KO, WT<sub>KO</sub><br>KI, WT<sub>KI</sub>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0329823.t003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="t003fn001"><p>* Outside of the KI region in the last exons.</p></div>
<div class="fn" id="t003fn002"><p><sup>#</sup>
<em>SNCA</em> knock-in (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_019169" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_019169</a>, bases 1–327 + <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000345" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000345</a>, bases 424–648) designed to produce signal only if the knock-in is present (captured human portion only).</p></div>
</div></section><p>As there was little previous characterization of the aSyn KO rat, two different probe sets for the <em>Snca</em> mRNA transcript were tested. aSyn KO rats had one base pair insertion in the <em>Snca</em> gene, which produces a premature stop codon in exon 4. Consequently, <em>Snca</em> probes were designed to lie both upstream and downstream of exon 4 to take into account the possibility that the KO genetic modification would result in the differential degradation of the transcript along the length of the mature mRNA. The design, implemented by Thermo Fisher Scientific as a highly customized assay, involved the probe sets binding to the same physical transcript, which would then shear (post-hybridization to the probe sets) in between the hybridized regions. Each piece (upstream: bases 3–309; downstream: bases 564–1082) then produced a unique signal that was measured independently.</p>
<p>The final QuantiGene panel IDs used were M20011701 for the aSyn A53T KI rats and their WT littermates, and M19073105 for the aSyn KO rats and their WT littermates.</p></section><section id="sec022"><h4 class="pmc_sec_title">QuantiGene Plex assay data processing.</h4>
<p>The non-normalized (median) fluorescence intensity (MFI) values reflecting mRNA expression levels of respective genes were obtained using either a Bio-Plex 200 reader (BioRad, Hercules, CA, USA) or MAGPIX System (Luminex Corporation, Austin, TX, USA) and converted to normalized gene expression values as detailed below. For assay quality control, the limit of detection was defined as the average MFI of the background control wells plus three standard deviations calculated for each assay plate. The signals below the thus defined limit of detection were not removed from analyses because such signals were in groups that were expected to generate low signal, and exclusion would have decreased the effective number of replicates. Thus, all values were used for statistical analyses, even though the exact values that were close to background may not have been precisely quantified (e.g., the expression level of the humanized A53T <em>SNCA</em> in WT animals). Additionally, after removing potential (technical) outliers, the MFI values were corrected to the baseline (each analyte separately) by subtracting the average MFI in the background wells. These net MFI values were averaged and then normalized by dividing each target gene signal (net MFI) by the geometric mean of the housekeeping genes (averaged and with background subtracted).</p></section><section id="sec023"><h4 class="pmc_sec_title">Western blot.</h4>
<p>For tissue homogenization, fractionation, and western blot analysis, we applied a slightly modified version of previously described protocol [<a href="#pone.0329823.ref021" class="usa-link" aria-describedby="pone.0329823.ref021">21</a>]. Tissue was homogenized using a FastPrep®-24 device in eight volumes (v/w) of the solution containing 50 mM HEPES-KOH, 1% Triton X-100, 750 mM NaCl, 5 mM EDTA (pH 7.6) supplemented with Complete Mini protease inhibitor cocktail and PhosSTOP phosphatase inhibitor cocktail (Roche Diagnostics). For fractionation, homogenates were normalized for the protein content and centrifuged at 16,100 g for 45 min at 4 °C. The collected supernatant comprised the soluble fraction, whereas the pellet was resuspended in four volumes of a solution containing 50 mM HEPES-NaOH and 1% SDS (pH = 7.6) and represented the insoluble fraction. Lysates normalized for the total protein concentration were then subjected to SDS-PAGE on Bis-Tris NuPAGE 4–12% gradient gels under reducing conditions and transferred to polyvinylidene difluoride membranes. The membranes were fixed with fresh 0.4% paraformaldehyde in PBS for 30 min and then incubated with the 4B12 antibody against human aSyn (MA-90346, Thermo Fisher Scientific), syn-1 antibody against total aSyn (clone 42, BD Biosciences, Franklin Lakes, NJ, USA), or C4 antibody against actin (MAB1501, MIllipore). Bound antibodies were detected and quantified by LICOR infrared imaging system and ImageStudio Lite 5.2.5 software, respectively. Whole blot images can be found in <a href="#pone.0329823.s003" class="usa-link">S3 Fig</a>.</p></section></section><section id="sec024"><h3 class="pmc_sec_title">HPLC</h3>
<p>Samples were derivatized using a slightly modified version of a previously reported method [<a href="#pone.0329823.ref022" class="usa-link" aria-describedby="pone.0329823.ref022">22</a>]. Briefly, 20ul of diluted homogenate was added to a round bottom 96 well plate. 10 ul of 100mM Sodium Carbonate was added to each sample and agitated by pipetting up and down for 5 seconds. Then, 10 ul of 2% Benzoyl Chloride was added to each sample and again pipetted up and down for 5 seconds. Finally, 10 ul of an internal standard mixture (containing 13C-benzoyl chloride labeled dopamine, HVA, DOPAC) was added to the sample and pipetted up and down. Samples were then loaded onto a Shimadzu Sil-20 AC autosampler which injected samples onto a Waters BEH C18 reverse phase column (2 mm ID x 5 cm long). Samples were separated and eluted over 10 minutes, and an AB Sciex 6500 triple quadrupole mass spectrometer was used to detect benzoylated dopamine (466 - &gt; 105), benzoylated HVA (304 - &gt; 105), and benzoylated DOPAC (394 - &gt; 105). Concentrations were calculated using a standard curve and the light:heavy internal standard ratio.</p></section><section id="sec025"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>All data are presented as the mean ± standard deviation (SD) or as box-whisker plots. For the analysis of gene and protein expression, data were pooled across sexes, whereas physiological and behavioral parameters were analyzed in males and females separately. Data were analyzed by the two-way analysis of variance (ANOVA) with genotype and age as factors. Data from consecutive measurements in the same animals were analyzed by averaging data from time bins and performing two-way repeated measures ANOVA with age and genotype as within-subject and between-subject factors, respectively. When factor interaction effects were statistically significant, Holm–Šídák’s multiple comparisons test to explore differences between genotypes at individual levels of the time or age factor. Data on striatal monoamine levels were analyzed using mixed-effects model (REML) with genotype and age as independent factors. Raw data can be found on Zenodo in the MJFF Data Repository collection (<a href="https://doi.org/10.5281/zenodo.16109481" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.5281/zenodo.16109481</a>).</p></section></section><section id="sec026"><h2 class="pmc_sec_title">Results</h2>
<section id="sec027"><h3 class="pmc_sec_title">Confirmation of rat aSyn knockout and human A53T aSyn knockin at mRNA and protein levels in mutant rats</h3>
<p>To confirm the genetic modifications, we first measured mRNA levels of rat <em>Snca</em> and human A53T <em>SNCA</em> mRNA. We confirmed expression of the human A53T <em>SCNA</em> mRNA in multiple brain regions of aSyn A53T KI rats and absence of this mRNA in the brain of WT animals (<a href="#pone.0329823.g001" class="usa-link">Fig 1B</a>, D, F, H, J) in cohorts of all four different ages. In turn, probe sets selective for the endogenous rat <em>Snca</em> gene generated a positive signal only in samples from WT rats, demonstrating successful ablation of endogenous rat <em>Snca</em> expression through humanization of the gene (<a href="#pone.0329823.g001" class="usa-link">Fig 1A</a>, C, E, G, I). Successful knockout of rat <em>Snca</em> was confirmed using upstream and downstream probe sets to the single base pair insertion in the aSyn KO rats (<a href="#pone.0329823.g002" class="usa-link">Fig 2</a>).</p>
<figure class="fig xbox font-sm" id="pone.0329823.g001"><h4 class="obj_head">Fig 1. The aSyn A53T KI rat line expresses A53T-mutated humanized <em>SNCA</em> gene without rat <em>Snca</em> in the brain.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334032_pone.0329823.g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f5/12334032/c1c988ad4b22/pone.0329823.g001.jpg" loading="lazy" height="1114" width="783" alt="Fig 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329823.g001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Transcript levels (designated as median fluorescence intensity (MFI) of endogenous rat <em>Snca</em> and mutated humanized <em>SNCA</em> genes were quantified in the right brain hemisphere samples using the QuantiGene Plex assay and normalized to the geometric mean of mRNA expression levels of housekeeping genes <em>Hmbs</em>, <em>Ppib</em>, and <em><em>G</em>apdh</em> in the cortex (A, B), hippocampus (C, D), striatum (E, F), substantia nigra (G, H), and cerebellum (I, J). Data are presented as box-whisker plots. Data were analyzed using ordinary two-way ANOVA with genotype and age as independent factors. If the genotype × age effect was significant, pairwise comparisons within the same age group were done by the Holm–Šídák’s multiple comparisons test as follows: ***<em>P</em> &lt; 0.001 ****<em>P</em> &lt; 0.0001. If the factor interaction effect was not significant, main genotype effect was illustrated as follows: <sup>####</sup><em>P</em> &lt; 0.0001.</p></figcaption></figure><figure class="fig xbox font-sm" id="pone.0329823.g002"><h4 class="obj_head">Fig 2. Confirmation of successful rat <em>Snca</em> depletion in the aSyn KO rat line.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334032_pone.0329823.g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f5/12334032/c67a2ff6c769/pone.0329823.g002.jpg" loading="lazy" height="1108" width="755" alt="Fig 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329823.g002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The QuantiGene Plex assay that utilized upstream and downstream probe sets for rat <em>Snca</em> showed specific signals (designated as Normalized MFI) only in samples from WT rats but not in samples from aSyn KO animals in the cortex (A), hippocampus (B), substantia nigra (C) and cerebellum (D). Data were analyzed using ordinary two-way ANOVA with genotype and age as independent factors. If the genotype × age effect was significant, pairwise comparisons within the same age group were done by the Holm–Šídák’s multiple comparisons test as follows: ****<em>P</em> &lt; 0.0001. If the factor interaction effect was not significant, main genotype effect was illustrated as follows: <sup>####</sup><em>P</em> &lt; 0.0001.</p></figcaption></figure><p>Next, we confirmed successful genetic modifications at the protein level. Western blots were performed in cortical extracts of aSyn KO rats and WT littermates using a mouse anti-aSyn antibody (clone 42, BD Biosciences), showing successful knockout of the aSyn protein in the aSyn KO rat line (<a href="#pone.0329823.g003" class="usa-link">Fig 3A</a>, B). To measure the expression of human aSyn in the aSyn A53T KI rat, we performed western blotting of cortical extracts using a monoclonal antibody specific to human aSyn (clone 4B12; Thermo Fisher Scientific), showing selective expression of the humanized aSyn in KI rats (<a href="#pone.0329823.g003" class="usa-link">Fig 3C</a>, D). Together, these observations confirm specificity of gene targeting and reliable brain mRNA and protein expression or loss thereof in the aSyn A53T KI and aSyn KO lines, respectively.</p>
<figure class="fig xbox font-sm" id="pone.0329823.g003"><h4 class="obj_head">Fig 3. Confirmed loss of aSyn protein the aSyn KO line and expression of human aSyn protein in the aSyn A53T KI line.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334032_pone.0329823.g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f5/12334032/465205d4de1a/pone.0329823.g003.jpg" loading="lazy" height="476" width="732" alt="Fig 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329823.g003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) Relative expression of rat aSyn in the cortex of aSyn KO and associated WT rats. (B) Western blot image of total aSyn and actin western blot in cortex of aSyn KO and WT rats. (C) Relative expression of human aSyn in the cortex of aSyn A53T KI and associated WT rats. (D) Western blot image of total aSyn, triton-soluble aSyn, and triton-insoluble aSyn in cortex of aSyn A53T KI and WT rats. Horizontal bars indicate the median value. Data were analyzed using two-way repeated measures ANOVA with genotype and age as independent factors. Main genotype effect was illustrated as follows: <sup>#</sup><em>P</em> &lt; 0.05.</p></figcaption></figure></section><section id="sec028"><h3 class="pmc_sec_title">Gastrointestinal function and locomotor behavior are not impaired in the aSyn A53T KI model</h3>
<p>Gross observations and body weight measurements were normal in the aSyn A53T KI rats. For a more granular look at the impact of the humanized A53T aSyn mutation on the rats, we performed detailed gastrointestinal and motor function analyses.</p>
<p>Gastrointestinal motility parameters, including stool counts and bead expulsion times, were largely similar in aSyn A53T KI and WT rats (<a href="#pone.0329823.g004" class="usa-link">Fig 4A</a>–<a href="#pone.0329823.g004" class="usa-link">D</a>).</p>
<figure class="fig xbox font-sm" id="pone.0329823.g004"><h4 class="obj_head">Fig 4. Gastrointestinal motility is generally unchanged in aSyn A53T KI rats.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334032_pone.0329823.g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f5/12334032/2359935e9dd7/pone.0329823.g004.jpg" loading="lazy" height="475" width="707" alt="Fig 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329823.g004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A, B) Stool counts in female and male aSyn A53T KI and WT rats of different ages. (C, D) Bead expulsion times in female and male aSyn A53T KI and WT rats of different ages. Data in A–D are presented as box-whisker plots. Data were analyzed using ordinary two-way ANOVA with genotype and age as independent factors (Stool count averaged over D1 and D2).</p></figcaption></figure><p>Assessment of behavior of aSyn A53T KI rats in the open field did not reveal any significant differences between the groups on the four parameters in females and males (<a href="#pone.0329823.g005" class="usa-link">Fig 5</a>). Two-way ANOVA with genotype and age as independent factors was conducted using sums of distances traveled or number of rearings over five-minutes time bins, except for the velocity, average velocity over the time bins was used.</p>
<figure class="fig xbox font-sm" id="pone.0329823.g005"><h4 class="obj_head">Fig 5. Open field locomotion is not robustly affected in aSyn A53T KI rats.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334032_pone.0329823.g005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f5/12334032/d1779dab0892/pone.0329823.g005.jpg" loading="lazy" height="877" width="660" alt="Fig 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329823.g005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Open field measures of total distance travelled (A, B), distance travelled in the center (C, D), number of rearings (E, F), and velocity (G, H). Data are presented as the mean ± S.D (n = 3–15). Statistical analysis was conducted from sums of distances traveled during time bins except for velocity average of velocity during time bins was used. Data were analyzed using ordinary two-way ANOVA with genotype and age as independent factors.</p></figcaption></figure><p>Next, we moved to monitoring animals in their home cages as this enables a less disruptive assessment of their behavior and readouts during sleep/wake cycles. We examined WT and aSyn A53T KI rats in continuous 72 h recordings, analyzing primarily distance travelled and duration of thigmotactic behavior (i.e., tendency to remain close to cage walls) in 1 h bins (<a href="#pone.0329823.g006" class="usa-link">Figs 6</a> and <a href="#pone.0329823.g007" class="usa-link">7</a>). Statistical analysis was performed on time bin averaged data using genotype and age as independent factors. The aSyn A53T KI rats demonstrated similar average distance travelled than WT in both males and females (<em>P</em> &gt; 0.05, two-way ANOVA interaction and main effect of Genotype) (<a href="#pone.0329823.g007" class="usa-link">Fig 7</a>).</p>
<figure class="fig xbox font-sm" id="pone.0329823.g006"><h4 class="obj_head">Fig 6. Distance travelled in home cage by A53T KI and WT rats.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334032_pone.0329823.g006.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f5/12334032/d5dc34628aee/pone.0329823.g006.jpg" loading="lazy" height="1147" width="796" alt="Fig 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329823.g006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Distance travelled in home cage by female (A, C, E, G) and male (B, D, F, H) A53T KI and WT rats. Data are presented as the mean ± S.D. (<em>n</em> = 8–10 per each hourly point). Gray boxes indicate periods with lights switched off. For statistical analysis the distance travelled during the measurement period within age month were averaged and analyzed using ordinary two-way ANOVA.</p></figcaption></figure><figure class="fig xbox font-sm" id="pone.0329823.g007"><h4 class="obj_head">Fig 7. Thigmotactic behavior in home cage of A53T KI and WT rats.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334032_pone.0329823.g007.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f5/12334032/b7b6a9979afc/pone.0329823.g007.jpg" loading="lazy" height="1146" width="796" alt="Fig 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329823.g007/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Thigmotactic behavior expressed as time spent near home cage walls in female (A, C, E, G) and male (B, D, F, H) A53T KI and WT rats. Data are presented as the mean ± S.D. (<em>n</em> = 8–10 per each hourly point). Gray boxes indicate periods with lights switched off. Averaged data were analyzed using ordinary two-way ANOVA with genotype and age as independent factors. If the genotype × age effect was significant, pairwise comparisons within the same age group were done by the Holm–Šídák’s multiple comparisons test as follows: *<em>P</em> &lt; 0.05.</p></figcaption></figure><p>A statistically significant interaction effect was observed in thigmotaxis in females (F <sub>(</sub><sub>3, 69</sub><sub>)</sub> = 5.467, <em>P</em> = 0.0020) with aSyn A53T KI animals showing less thigmotaxis at 4 months of age (<em>P</em> = 0.0437, Holm-Šidák’s test) and more thigmotaxis at 12 months of age (<em>P</em> = 0.0306) (<a href="#pone.0329823.g007" class="usa-link">Fig 7</a>). Given the inconsistent direction of change and minimal differences, these thigmotaxis differences do not seem physiologically relevant.</p>
<p>Additionally, we assessed balance using the beam walk test. Analysis of performance of aSyn A53T KI and WT rats in this test similarly showed that mutant animals had generally unperturbed sensorimotor function (<a href="#pone.0329823.g008" class="usa-link">Fig 8</a>). A significant Genotype × Age interaction effect was observed for the front limb slip ratio in female rats (F <sub>(</sub><sub>3, 76</sub><sub>)</sub> = 4.115; <em>P</em> = 0.0092) at 18 months of age (<em>P =</em> 0.0268; Holm-Šídák’s multiple comparisons test), however appears to be due to an increase in slips in the WT line rather than motor dysfunction in the A53T aSyn KI line.</p>
<figure class="fig xbox font-sm" id="pone.0329823.g008"><h4 class="obj_head">Fig 8. Beam walk test in A53T KI and WT rats reveals minor disturbances in front limbs in males only.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334032_pone.0329823.g008.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f5/12334032/6e184fd9f18f/pone.0329823.g008.jpg" loading="lazy" height="501" width="697" alt="Fig 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329823.g008/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Ratio percentage of front limb slips (A, B) and hind limb slips (C, D) in female and male rats. L + R = left + right. Data are presented as box-whisker plots. Data were analyzed using ordinary two-way ANOVA with genotype and age as independent factors. If the genotype × age effect was significant, pairwise comparisons within the same age group were done by the Holm–Šídák’s multiple comparisons test as follows: *<em>P</em> &lt; 0.05.</p></figcaption></figure><p>Finally, kinematic analysis of fine motor skills was performed with Principal Component Analysis (PCA) of individual gait parameters measured in the MotoRater apparatus (<a href="#pone.0329823.s004" class="usa-link">S4</a> and <a href="#pone.0329823.s005" class="usa-link">S5 Figs</a>). The overall gait score expressed as distance from the pooled score of all WT animals of the corresponding age was influenced by both the genotype and age (<a href="#pone.0329823.g009" class="usa-link">Fig 9</a>). In particular, we found that genotype had a significant effect on the gait overall score in both females (F<sub>(1, 69)</sub> = 10.51; <em>P</em> = 0.0018) and males (F<sub>(1, 52)</sub> = 6.953; <em>P</em> = 0.011). Likewise, age had a significant impact on both female (F<sub>(3, 69)</sub> = 3.082; <em>P</em> = 0.033) and male rats (F<sub>(3, 52)</sub> = 6.297; <em>P</em> = 0.001). In addition, the genotype × age interaction had a significant effect on the gait score in male rats (F<sub>(3, 52)</sub> = 3.281; <em>P</em> = 0.028). The Holm–Šídák’s multiple comparisons test indicated that the difference in males was particularly significant between 18-month-old aSyn A53T KI and WT male rats (<em>P</em> = 0.0071; <a href="#pone.0329823.g009" class="usa-link">Fig 9B</a>). Further dissection of the genotype × age interaction effect in male rats showed that in WT animals, the gait score in 8-month-old (but not 12- or 18-month-old) animals was significantly higher than in 4-month-old animals (<em>P</em> = 0.0219, Dunnett’s test). In contrast, in aSyn A53T KI rats, the gait scores in 12- and 18-month-old (but not 8-month-old) animals were significantly higher than in 4-month-old animals (<em>P</em> = 0.0187 and <em>P</em> = 0.0006, respectively).</p>
<figure class="fig xbox font-sm" id="pone.0329823.g009"><h4 class="obj_head">Fig 9. Kinematic analysis of fine motor skills in A53T KI and WT rats.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f5/12334032/81ed35b46fbd/pone.0329823.g009.jpg" loading="lazy" height="1004" width="750" alt="Fig 9"></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329823.g009/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Gait overall score was calculated in 4-, 8-, 12-, and 18-month-old female (A) and male (B) rats as described previously [<a href="#pone.0329823.ref019" class="usa-link" aria-describedby="pone.0329823.ref019">19</a>]. Ordinary Two-way ANOVA results are indicated as follows: <sup>##</sup><em>P</em> &lt; 0.01, main genotype effect; **<em>P</em> &lt; 0.01, Holm–Šídák’s multiple comparisons test.</p></figcaption></figure></section><section id="sec029"><h3 class="pmc_sec_title">aSyn A53T KI and aSyn KO rats do not display nigrostriatal degeneration</h3>
<p>To assess degeneration of the nigrostriatal system, we first analyzed striatal dopamine neurochemistry to determine if nigrostriatal terminals were impacted in the aSyn A53T KI or aSyn KO rat lines. HPLC analysis of striatal samples of aSyn A53T KI, aSyn KO, and corresponding WT littermates showed that neither genotype nor the genotype × age interaction affected levels of striatal dopamine or its primary metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in mutant rats (<a href="#pone.0329823.g010" class="usa-link">Fig 10</a>). The only statistically significant effect was the overall decrease in HVA content in aSyn A53T KI and WT rats with age (F <sub>(</sub><sub>1, 16</sub><sub>)</sub> = 34.56, <em>P</em> &lt; 0.0001, main effect of age).</p>
<figure class="fig xbox font-sm" id="pone.0329823.g010"><h4 class="obj_head">Fig 10. The humanized A53T aSyn KI and endogenous rat aSyn KO do not result in striatal neurochemistry deficits.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334032_pone.0329823.g010.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f5/12334032/5e9ec41b0117/pone.0329823.g010.jpg" loading="lazy" height="735" width="673" alt="Fig 10"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329823.g010/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Striatal levels of dopamine (A, B), DOPAC (C, D), and HVA (E, F) were determined using HPLC in samples of 4- and 18-month-old aSyn A53T KI rats and 6- as well as 12-month-old aSyn KO rats and associated WT littermates. Data were analyzed using Mixed-effects model (REML) with genotype and age as independent factors. Results are indicated as follows: ***<em>P</em> &lt; 0.001 age effect.</p></figcaption></figure><p>Furthermore, we performed immunohistochemical staining for TH in the SNpc to quantify nigral dopamine neurons in the aSyn A53T KI model. Staining and stereology of thin brain sections showed similar numbers of TH<sup>+</sup> cells in the SNpc of the aSyn A53T KI and WT rats (main effect of genotype: F<sub>(1, 59)</sub> = 1.197, <em>P</em> = 0.278), indicating that the humanized A53T mutation does not spontaneously lead to degeneration of dopaminergic neurons (<a href="#pone.0329823.g011" class="usa-link">Fig 11</a>).</p>
<figure class="fig xbox font-sm" id="pone.0329823.g011"><h4 class="obj_head">Fig 11. aSyn A53T KI do not display nigral neuron loss.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334032_pone.0329823.g011.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f5/12334032/61b6e5c25fdc/pone.0329823.g011.jpg" loading="lazy" height="712" width="736" alt="Fig 11"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329823.g011/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) Box-whisker plots of TH<sup>+</sup> cell numbers in the SNpc of aSyn A53T KI and WT rats. (B) Images of midbrain sections stained for TH to visualize dopaminergic neurons in the SNpc.</p></figcaption></figure></section><section id="sec030"><h3 class="pmc_sec_title">aSyn A53T KI rats do not display gastrointestinal or brain pathology</h3>
<p>Although nigrostriatal degeneration and gastrointestinal (GI) dysfunction were not observed in this model, we wanted to confirm if neurodegeneration-related pathology was present in the brain and GI tract. We selected 18–month-old animals for this study, as aSyn, tau, and inflammation-related pathology would be most likely observed in aged animals.</p>
<p>Regarding aSyn expression, we observed similar total aSyn protein levels in the GI tract and brain between aSyn A53T KI rats and WT littermates when using an antibody that recognizes both rat and human aSyn, indicating physiologically-relevant aSyn expression levels in the aSyn A53T KI rat (<a href="#pone.0329823.g012" class="usa-link">Fig 12A</a>–<a href="#pone.0329823.g012" class="usa-link">C</a>). pS129 aSyn pathology was not observed in the SNpc, colon, or duodenum of aSyn A53T rats (<a href="#pone.0329823.g012" class="usa-link">Fig 12D</a>–<a href="#pone.0329823.g012" class="usa-link">F</a>). Additional markers of brain pathology--including pS202/T205 tau pathology in the cortex, microgliosis in the substantia nigra, and astrogliosis in the brain--were not observed in the aSyn A53T KI model at 18 months of age (<a href="#pone.0329823.g013" class="usa-link">Fig 13</a>).</p>
<figure class="fig xbox font-sm" id="pone.0329823.g012"><h4 class="obj_head">Fig 12. aSyn A53T KI do not display aSyn pathology in the SNpc or gastrointestinal system.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334032_pone.0329823.g012.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f5/12334032/9cd23f7db4cc/pone.0329823.g012.jpg" loading="lazy" height="280" width="750" alt="Fig 12"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329823.g012/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A-C) Representative images of staining for human/rat aSyn in the (A) midbrain, (B) colon, and (C) duodenum of WT and aSyn A53T KI rats. stained for human/rat aSyn. (D-F) Representative images of staining for pS129 aSyn in the (D) SNpc at 20x, (E) colon, and (F) duodenum. Colon and duodenum display high background fluorescence for pS129 aSyn.</p></figcaption></figure><figure class="fig xbox font-sm" id="pone.0329823.g013"><h4 class="obj_head">Fig 13. aSyn A53T KI do not display tau pathology or neuroinflammation in brain.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24f5/12334032/f004ef90bb2b/pone.0329823.g013.jpg" loading="lazy" height="1164" width="723" alt="Fig 13"></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329823.g013/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) Representative images of staining for pS202/T205 tau in the cortex of WT and aSyn A53T KI mice. (B) Representative images of staining for Iba1-positive microglia in the SNpc at 10x and 20x magnification. (C) Representative images of GFAP-positive astrocytes in the brain.</p></figcaption></figure></section></section><section id="sec031"><h2 class="pmc_sec_title">Discussion</h2>
<p>Alpha-synuclein is linked to Parkinson’s disease through <em>SNCA</em> genetic mutations, presence of phosphorylated aSyn in Lewy bodies and Lewy neurites, and evidence of aggregated aSyn in PD patient cerebrospinal fluid. While many rodent models are currently available to study alpha-synuclein in the context of PD, a key gap in the field is a model that expresses human aSyn at physiological levels without the presence of endogenous rodent aSyn. To address this gap, The Michael J. Fox Foundation for Parkinson’s Research developed a novel A53T aSyn rat line using CRISPR/Cas9 to humanize the amino acids surrounding the naturally occurring threonine 53 in the Sprague Dawley rat, resulting in expression of human A53T aSyn without endogenous rat aSyn. Simultaneously, we also developed an aSyn KO Sprague Dawley rat model to confirm that phenotypes/pathology observed were not due to the absence of endogenous rat aSyn. Both models lack expression of rat <em>Snca</em> mRNA and aSyn protein (<a href="#pone.0329823.g001" class="usa-link">Figs 1</a>–<a href="#pone.0329823.g003" class="usa-link">3</a>), with the aSyn A53T KI line successfully expressing human A53T <em>SNCA</em> mRNA and aSyn protein throughout the brain (<a href="#pone.0329823.g001" class="usa-link">Figs 1</a> and <a href="#pone.0329823.g003" class="usa-link">3</a>). Furthermore, immunostaining with an antibody that cross-reacts with human and rat aSyn indicates generally equivalent aSyn expression levels between WT and aSyn A53T KI rats (<a href="#pone.0329823.g012" class="usa-link">Fig 12</a>), confirming physiological expression levels of human aSyn in this model.</p>
<p>We next evaluated face validity of the aSyn A53T KI rat model by profiling PD-like motor phenotypes, gastrointestinal phenotypes, nigrostriatal degeneration, and various markers of brain pathology to determine whether physiological expression of human A53T aSyn initiated PD-like phenotypes/pathology as occurs in patients [<a href="#pone.0329823.ref002" class="usa-link" aria-describedby="pone.0329823.ref002">2</a>] and models overexpressing human A53T aSyn [<a href="#pone.0329823.ref012" class="usa-link" aria-describedby="pone.0329823.ref012">12</a>,<a href="#pone.0329823.ref013" class="usa-link" aria-describedby="pone.0329823.ref013">13</a>]. We extensively profiled motor behaviors in this model up to 18 months of age given the universal prevalence and progressive nature of motor dysfunction in Parkinson’s disease. We did not observe deficits in open field testing (<a href="#pone.0329823.g005" class="usa-link">Fig 5</a>) or the less intrusive homecage behavior monitoring (<a href="#pone.0329823.g006" class="usa-link">Fig 6</a>), and the beam walk test remained largely unaffected (<a href="#pone.0329823.g008" class="usa-link">Fig 8</a>). While fine motor differences were observed in males at 18 months (<a href="#pone.0329823.g009" class="usa-link">Fig 9</a>), the lack of deficits in other motor readouts indicate that this might be a subtle difference that is difficult to measure or detect. It would be prudent to test additional sensitive measures of motor disturbance in 18 month old male aSyn A53T KI rats in the future to determine if this phenotype is robust and reliable.</p>
<p>Regarding non-motor symptoms, gastrointestinal dysfunction, sleep disturbances, and anxiety are common in PD patients [<a href="#pone.0329823.ref023" class="usa-link" aria-describedby="pone.0329823.ref023">23</a>], with gastrointestinal dysfunction and sleep disturbances appearing prior to motor dysfunction [<a href="#pone.0329823.ref024" class="usa-link" aria-describedby="pone.0329823.ref024">24</a>–<a href="#pone.0329823.ref026" class="usa-link" aria-describedby="pone.0329823.ref026">26</a>]. We profiled gastrointestinal function in the aSyn A53T KI rats using a variety of tests and found no evidence of robust changes up to 18 months of age (<a href="#pone.0329823.g004" class="usa-link">Fig 4</a>). Evidence of anxiety-like phenotypes can be gleaned from the open field and homecage monitoring tests [<a href="#pone.0329823.ref027" class="usa-link" aria-describedby="pone.0329823.ref027">27</a>]. Rats did not show overt differences in distance travelled in the center during the open field test (<a href="#pone.0329823.g005" class="usa-link">Fig 5C</a>, D), and time spent near the walls in the home cage monitoring was not meaningfully different between aSyn A53T KI rats and WT littermates (<a href="#pone.0329823.g007" class="usa-link">Fig 7</a>). Finally, activity patterns during light/dark cycles were similar between aSyn A53T KI rats and WT littermates indicating no overt sleep dysfunction in the model (<a href="#pone.0329823.g006" class="usa-link">Figs 6</a> and <a href="#pone.0329823.g007" class="usa-link">7</a>). It is important to note, however, that these measures of anxiety and sleep are rudimentary and baseline, and more thorough investigation of anxiety or sleep dysfunction using additional tests, technologies, or stressors may uncover phenotypes. Furthermore, additional tests on gastrointestinal function, like whole gut transit time, may uncover phenotypes due to dysfunction in anterior parts of the gut as the methods used here focused more on colonic and lower intestine function.</p>
<p>To determine whether PD-like pathology is present within the brain, we performed a detailed analysis of nigrostriatal integrity at the level of the striatal neuron terminals and nigral cell bodies. Dopamine and dopamine metabolite neurochemistry in the striatum was unchanged in the aSyn A53T KI rat model up to 18 months of age (<a href="#pone.0329823.g010" class="usa-link">Fig 10</a>), and nigral TH+ neuron numbers remain unchanged up to 18 months as well (<a href="#pone.0329823.g011" class="usa-link">Fig 11</a>). This lack of nigrostriatal degeneration supports the lack of motor dysfunction observed in the model. Furthermore, we examined total aSyn, pS129 aSyn, pS202/T205 Tau, microgliosis, and astrogliosis in the brain through immunostaining and found no evidence of increases or changes in these markers in aSyn A53T KI rats at 18 months of age (<a href="#pone.0329823.g012" class="usa-link">Figs 12</a> and <a href="#pone.0329823.g013" class="usa-link">13</a>). Similarly, total aSyn and pS129 aSyn levels in the colon and duodenum were equivalent between WT and aSyn A53T KI rats (<a href="#pone.0329823.g012" class="usa-link">Fig 12</a>).</p>
<p>Taken together, the aSyn A53T KI rat model remains relatively unimpaired up to 18 months of age, with no robust phenotypes related to motor dysfunction, non-motor dysfunction, nigrostriatal degeneration, or brain pathology at baseline. Although this model cannot be recommended as a model of parkinsonism at baseline, we are reassured by these findings as they align with evidence in mouse models that near-physiological expression of human WT or mutant aSyn do not result in robust PD-relevant phenotypes [<a href="#pone.0329823.ref012" class="usa-link" aria-describedby="pone.0329823.ref012">12</a>]. As this is a humanized knockin model, expression of human aSyn is at physiological levels (<a href="#pone.0329823.g012" class="usa-link">Fig 12A</a>–<a href="#pone.0329823.g012" class="usa-link">C</a>) and driven by endogenous machinery, therefore making expression levels and patterns more similar to WT than transgenic or BAC/PAC models. This suggests that there are factors outside of the sequence of human aSyn that lead to pathology and Parkinson’s disease in humans. The design of this humanized knockin model enables the introduction of such factors through crosses with other genetically-modified rat models, injection of alpha-synuclein PFF aggregates, or administration of environmental exposures to study the impact of external factors on PD development and pathology driven by human aSyn.</p>
<p>Although the complex etiology of Parkinson’s disease is largely unclear in most cases, environmental risk factors and the propensity of aSyn aggregates to seed the formation of new aggregates in endogenous monomeric protein highlight the importance of investigating external triggers of PD pathogenesis [<a href="#pone.0329823.ref028" class="usa-link" aria-describedby="pone.0329823.ref028">28</a>,<a href="#pone.0329823.ref029" class="usa-link" aria-describedby="pone.0329823.ref029">29</a>]. To effectively investigate these triggers and understand their relevance, processes, and possible therapeutic interventions, <em>in vivo</em> model systems that express human aSyn are important. For instance, recent structural studies of the aggregated aSyn protein revealed differences between human and mouse aSyn aggregate properties. Specifically, recombinant human and mouse aSyn pre-formed fibrils used in PD seeding models have different structural properties which confer differences in seeding ability. Furthermore, when seeding across species (e.g., human aSyn PFFs in mice or recombinant mouse aSyn) the newly templated aggregates have different properties from the original PFF seeding material. This highlights the importance of using models expressing human aSyn without endogenous rodent aSyn, like the aSyn A53T KI rat, in PFF models designed to study human aSyn aggregate properties or to test therapies directed at human aSyn aggregate structures.</p>
<p>In summary, the aSyn A53T KI rat line is a well-characterized model that does not display PD-like behaviors or pathology up to 18 months of age. As the aSyn A53T KI and aSyn KO rat lines were developed by and are shared openly through The Michael J. Fox Foundation’s Research Tools Program (michaeljfox.org/research-tools), we encourage others to access the lines and investigate their utility in combination with aSyn PFFs, environment stressors, and other dual-hit models. For instance, future studies focusing on viral, toxin, or pollution exposures in this aSyn A53T KI rat model could expose new biological findings on the mechanism by which these risk factors interact with human aSyn and increase the risk for Parkinson’s disease. Furthermore, injecting human aSyn PFFs into the aSyn A53T KI rat to characterize pathology and resulting aSyn aggregate structures would potentially open new, more human-relevant <em>in vivo</em> systems for testing therapeutic strategies directed towards aSyn aggregates. These are important research avenues that should be pursued moving forward.</p></section><section id="sec032"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="pone.0329823.s001"><div class="caption p">
<span>S1 Fig. CRISPR editing design and resulting sequence of the aSyn A53T KI rat.</span><p>Editing design and humanized sequence in the aSyn A53T KI rat. (A) Visual schematic of the editing design depicting homology arm left (HAL), the targeted exon 4 region and replacement with partial human <em>SNCA</em> cDNA, the BGHpA-SV40pA, and the homology arm right (HAR). (B) Sequence alignment comparing the rat aSyn, human aSyn, and the sequence of the human aSyn cDNA incorporated into the model. Yellow highlight indicates the endogenous threonine at amino acid 53 in rat aSyn which was maintained in the aSyn A53T KI line. Pink highlights indicate amino acid differences between rat and human aSyn. Green highlight indicates the amino acids that were altered in rat aSyn through the incorporation of the partial human cDNA. (C) DNA sequencing of donor DNA used for the CRISPR edit, indicating homology arms in black, partial human SNCA cDNA sequence in blue, and BGHpA-SV40pA in orange.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334032/bin/pone.0329823.s001.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0329823.s001.tif</a><sup> (1.1MB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0329823.s002"><div class="caption p">
<span>S2 Fig. Positive control tissue for pathological marker immunostaining.</span><p>(A) Representative images of staining for pS202/T205 tau in the cortex of P301S tau transgenic mice. (B) Representative images of staining for pS129 aSyn in the SNpc of LRRK2 G2019S KI mice injected with adeno-associated virus to overexpress human A53T aSyn.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334032/bin/pone.0329823.s002.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0329823.s002.tif</a><sup> (688.4KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0329823.s003"><div class="caption p">
<span>S3 Fig. Uncropped western blot images corresponding to Fig 3.</span><p>Uncropped and unadjusted western blot image of (A) total aSyn and actin control in aSyn KO and WT littermate rats, (B) total aSyn, triton-soluble aSyn, triton-insoluble aSyn and actin control in aSyn A53T KI and WT littermate rats.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334032/bin/pone.0329823.s003.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0329823.s003.tif</a><sup> (622KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0329823.s004"><div class="caption p">
<span>S4 Fig. Gait characteristics and fine motor skills during walking in female aSyn A53T KI and WT rats.</span><p>Principal component scores generated by the principal component analysis of analysis of different gait patterns and movements. Movement of different body points in relation to the ground and their correlation in the three spatial dimensions was examined. Data are presented as the mean ± standard error of the mean. Statistical significance of differences is illustrated as follows: <sup>#</sup><em>P</em> &lt; 0.05; <sup>##</sup><em>P</em> &lt; 0.01 (Student’s <em>t</em>-test). The Correlation heat map depicts the degree of correlation for each walking parameter in the whole data set. Red color means positive correlation and blue means negative correlation. Number in the X-axis represents corresponding PC number.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334032/bin/pone.0329823.s004.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0329823.s004.tif</a><sup> (317.7KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0329823.s005"><div class="caption p">
<span>S5 Fig. Gait characteristics and fine motor skills during walking in male aSyn A53T KI and WT rats.</span><p>Principal component scores generated by the principal component analysis of analysis of different gait patterns and movements. Movement of different body points in relation to the ground and their correlation in the three spatial dimensions was examined. Data are presented as the mean ± standard error of the mean. Statistical significance of differences is illustrated as follows: <sup>#</sup><em>P</em> &lt; 0.05; <sup>##</sup><em>P</em> &lt; 0.01 (Student’s <em>t</em>-test). The Correlation heat map depicts the degree of correlation for each walking parameter in the whole data set. Red color means positive correlation and blue means negative correlation. Number in the X-axis represents corresponding PC number.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334032/bin/pone.0329823.s005.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0329823.s005.tif</a><sup> (260.5KB, tif) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The authors appreciate the input of all the representatives of The Michael J. Fox Foundation for Parkinson’s Research Industry Tools Consortium for helpful recommendations regarding generation and phenotypic characterization of the aSyn KO and aSyn A53T KI rat models. MJFF appreciates the in-kind support from Biogen for aSyn protein analysis and striatal neurochemistry experiments.</p></section><section id="notes1"><h2 class="pmc_sec_title">Data Availability</h2>
<p>The data underlying the results presented in the study are available from the MJFF Data Repository on Zenodo at <a href="https://doi.org/10.5281/zenodo.16109481" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.5281/zenodo.16109481</a>.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>This work was supported by the following Research Tools Program grants from The Michael J. Fox Foundation for Parkinson’s Research (michaeljfox.org): Grant Nos. 14580, 14580.01, 14585, 14585.01, and 14585.03 all awarded to TP. The funder (NKP) acts as the submitting author and has contributed to study design, decision to publish, and preparation of the manuscript.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="pone.0329823.ref001">
<span class="label">1.</span><cite>Dorsey ER, Sherer T, Okun MS, Bloem BR. The Emerging Evidence of the Parkinson Pandemic. J Parkinsons Dis. 2018;8(s1):S3–8. doi: 10.3233/JPD-181474

</cite> [<a href="https://doi.org/10.3233/JPD-181474" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6311367/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30584159/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Parkinsons%20Dis&amp;title=The%20Emerging%20Evidence%20of%20the%20Parkinson%20Pandemic&amp;author=ER%20Dorsey&amp;author=T%20Sherer&amp;author=MS%20Okun&amp;author=BR%20Bloem&amp;volume=8&amp;publication_year=2018&amp;pmid=30584159&amp;doi=10.3233/JPD-181474&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref002">
<span class="label">2.</span><cite>Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science. 1997;276(5321):2045–7. doi: 10.1126/science.276.5321.2045

</cite> [<a href="https://doi.org/10.1126/science.276.5321.2045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9197268/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Mutation%20in%20the%20alpha-synuclein%20gene%20identified%20in%20families%20with%20Parkinson%E2%80%99s%20disease&amp;author=MH%20Polymeropoulos&amp;author=C%20Lavedan&amp;author=E%20Leroy&amp;author=SE%20Ide&amp;author=A%20Dehejia&amp;volume=276&amp;issue=5321&amp;publication_year=1997&amp;pages=2045-7&amp;pmid=9197268&amp;doi=10.1126/science.276.5321.2045&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref003">
<span class="label">3.</span><cite>Krüger R, Kuhn W, Müller T, Woitalla D, Graeber M, Kösel S, et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson’s disease. Nat Genet. 1998;18(2):106–8. doi: 10.1038/ng0298-106
</cite> [<a href="https://doi.org/10.1038/ng0298-106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9462735/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Genet&amp;title=AlaSOPro%20mutation%20in%20the%20gene%20encoding%20%CE%B1-synuclein%20in%20Parkinson%E2%80%99s%20disease&amp;author=R%20Kr%C3%BCger&amp;author=W%20Kuhn&amp;author=T%20M%C3%BCller&amp;author=D%20Woitalla&amp;author=M%20Graeber&amp;volume=18&amp;issue=2&amp;publication_year=1998&amp;pages=106-8&amp;pmid=9462735&amp;doi=10.1038/ng0298-106&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref004">
<span class="label">4.</span><cite>Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, et al. alpha-Synuclein locus triplication causes Parkinson’s disease. Science. 2003;302(5646):841. doi: 10.1126/science.1090278

</cite> [<a href="https://doi.org/10.1126/science.1090278" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14593171/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=alpha-Synuclein%20locus%20triplication%20causes%20Parkinson%E2%80%99s%20disease&amp;author=AB%20Singleton&amp;author=M%20Farrer&amp;author=J%20Johnson&amp;author=A%20Singleton&amp;author=S%20Hague&amp;volume=302&amp;issue=5646&amp;publication_year=2003&amp;pages=841&amp;pmid=14593171&amp;doi=10.1126/science.1090278&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref005">
<span class="label">5.</span><cite>Chartier-Harlin M-C, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, et al. Alpha-synuclein locus duplication as a cause of familial Parkinson’s disease. Lancet. 2004;364(9440):1167–9. doi: 10.1016/S0140-6736(04)17103-1

</cite> [<a href="https://doi.org/10.1016/S0140-6736(04)17103-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15451224/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Alpha-synuclein%20locus%20duplication%20as%20a%20cause%20of%20familial%20Parkinson%E2%80%99s%20disease&amp;author=M-C%20Chartier-Harlin&amp;author=J%20Kachergus&amp;author=C%20Roumier&amp;author=V%20Mouroux&amp;author=X%20Douay&amp;volume=364&amp;issue=9440&amp;publication_year=2004&amp;pages=1167-9&amp;pmid=15451224&amp;doi=10.1016/S0140-6736(04)17103-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref006">
<span class="label">6.</span><cite>Zarranz JJ, Alegre J, Gómez-Esteban JC, Lezcano E, Ros R, Ampuero I, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol. 2004;55(2):164–73. doi: 10.1002/ana.10795

</cite> [<a href="https://doi.org/10.1002/ana.10795" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14755719/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Neurol&amp;title=The%20new%20mutation,%20E46K,%20of%20alpha-synuclein%20causes%20Parkinson%20and%20Lewy%20body%20dementia&amp;author=JJ%20Zarranz&amp;author=J%20Alegre&amp;author=JC%20G%C3%B3mez-Esteban&amp;author=E%20Lezcano&amp;author=R%20Ros&amp;volume=55&amp;issue=2&amp;publication_year=2004&amp;pages=164-73&amp;pmid=14755719&amp;doi=10.1002/ana.10795&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref007">
<span class="label">7.</span><cite>Appel‐Cresswell S, Vilarino‐Guell C, Encarnacion M, Sherman H, Yu I, Shah B, et al. Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson’s disease. Movement Disorders. 2013;28(6):811–3. doi: 10.1002/mds.25421
</cite> [<a href="https://doi.org/10.1002/mds.25421" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23457019/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Movement%20Disorders&amp;title=Alpha%E2%80%90synuclein%20p.H50Q,%20a%20novel%20pathogenic%20mutation%20for%20Parkinson%E2%80%99s%20disease&amp;author=S%20Appel%E2%80%90Cresswell&amp;author=C%20Vilarino%E2%80%90Guell&amp;author=M%20Encarnacion&amp;author=H%20Sherman&amp;author=I%20Yu&amp;volume=28&amp;issue=6&amp;publication_year=2013&amp;pages=811-3&amp;pmid=23457019&amp;doi=10.1002/mds.25421&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref008">
<span class="label">8.</span><cite>Kiely AP, Asi YT, Kara E, Limousin P, Ling H, Lewis P, et al. α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy?
Acta Neuropathol. 2013;125(5):753–69. doi: 10.1007/s00401-013-1096-7

</cite> [<a href="https://doi.org/10.1007/s00401-013-1096-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3681325/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23404372/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathol&amp;title=%CE%B1-Synucleinopathy%20associated%20with%20G51D%20SNCA%20mutation:%20a%20link%20between%20Parkinson%E2%80%99s%20disease%20and%20multiple%20system%20atrophy?&amp;author=AP%20Kiely&amp;author=YT%20Asi&amp;author=E%20Kara&amp;author=P%20Limousin&amp;author=H%20Ling&amp;volume=125&amp;issue=5&amp;publication_year=2013&amp;pages=753-69&amp;pmid=23404372&amp;doi=10.1007/s00401-013-1096-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref009">
<span class="label">9.</span><cite>Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388(6645):839–40. doi: 10.1038/42166

</cite> [<a href="https://doi.org/10.1038/42166" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9278044/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Alpha-synuclein%20in%20Lewy%20bodies&amp;author=MG%20Spillantini&amp;author=ML%20Schmidt&amp;author=VM%20Lee&amp;author=JQ%20Trojanowski&amp;author=R%20Jakes&amp;volume=388&amp;issue=6645&amp;publication_year=1997&amp;pages=839-40&amp;pmid=9278044&amp;doi=10.1038/42166&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref010">
<span class="label">10.</span><cite>Huntington TE, Srinivasan R. Adeno-Associated Virus Expression of α-Synuclein as a Tool to Model Parkinson’s Disease: Current Understanding and Knowledge Gaps. Aging Dis. 2021;12(4):1120–37. doi: 10.14336/AD.2021.0517

</cite> [<a href="https://doi.org/10.14336/AD.2021.0517" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8219504/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34221553/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Aging%20Dis&amp;title=Adeno-Associated%20Virus%20Expression%20of%20%CE%B1-Synuclein%20as%20a%20Tool%20to%20Model%20Parkinson%E2%80%99s%20Disease:%20Current%20Understanding%20and%20Knowledge%20Gaps&amp;author=TE%20Huntington&amp;author=R%20Srinivasan&amp;volume=12&amp;issue=4&amp;publication_year=2021&amp;pages=1120-37&amp;pmid=34221553&amp;doi=10.14336/AD.2021.0517&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref011">
<span class="label">11.</span><cite>Polinski NK. A Summary of Phenotypes Observed in the In Vivo Rodent Alpha-Synuclein Preformed Fibril Model. J Parkinsons Dis. 2021;11(4):1555–67. doi: 10.3233/JPD-212847

</cite> [<a href="https://doi.org/10.3233/JPD-212847" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8609716/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34486988/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Parkinsons%20Dis&amp;title=A%20Summary%20of%20Phenotypes%20Observed%20in%20the%20In%20Vivo%20Rodent%20Alpha-Synuclein%20Preformed%20Fibril%20Model&amp;author=NK%20Polinski&amp;volume=11&amp;issue=4&amp;publication_year=2021&amp;pages=1555-67&amp;pmid=34486988&amp;doi=10.3233/JPD-212847&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref012">
<span class="label">12.</span><cite>Fernagut P-O, Chesselet M-F. Alpha-synuclein and transgenic mouse models. Neurobiol Dis. 2004;17(2):123–30. doi: 10.1016/j.nbd.2004.07.001

</cite> [<a href="https://doi.org/10.1016/j.nbd.2004.07.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15474350/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurobiol%20Dis&amp;title=Alpha-synuclein%20and%20transgenic%20mouse%20models&amp;author=P-O%20Fernagut&amp;author=M-F%20Chesselet&amp;volume=17&amp;issue=2&amp;publication_year=2004&amp;pages=123-30&amp;pmid=15474350&amp;doi=10.1016/j.nbd.2004.07.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref013">
<span class="label">13.</span><cite>Johnson SJ, Wade-Martins R. A BACwards glance at neurodegeneration: molecular insights into disease from LRRK2, SNCA and MAPT BAC-transgenic mice. Biochem Soc Trans. 2011;39(4):862–7. doi: 10.1042/BST0390862

</cite> [<a href="https://doi.org/10.1042/BST0390862" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21787314/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem%20Soc%20Trans&amp;title=A%20BACwards%20glance%20at%20neurodegeneration:%20molecular%20insights%20into%20disease%20from%20LRRK2,%20SNCA%20and%20MAPT%20BAC-transgenic%20mice&amp;author=SJ%20Johnson&amp;author=R%20Wade-Martins&amp;volume=39&amp;issue=4&amp;publication_year=2011&amp;pages=862-7&amp;pmid=21787314&amp;doi=10.1042/BST0390862&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref014">
<span class="label">14.</span><cite>Dehay B, Fernagut P-O. Alpha-synuclein-based models of Parkinson’s disease. Rev Neurol (Paris). 2016;172(6–7):371–8. doi: 10.1016/j.neurol.2016.04.003

</cite> [<a href="https://doi.org/10.1016/j.neurol.2016.04.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27158042/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Rev%20Neurol%20(Paris)&amp;title=Alpha-synuclein-based%20models%20of%20Parkinson%E2%80%99s%20disease&amp;author=B%20Dehay&amp;author=P-O%20Fernagut&amp;volume=172&amp;publication_year=2016&amp;pages=371-8&amp;pmid=27158042&amp;doi=10.1016/j.neurol.2016.04.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref015">
<span class="label">15.</span><cite>Carta AR, Boi L, Pisanu A, Palmas MF, Carboni E, De Simone A. Advances in modelling alpha-synuclein-induced Parkinson’s diseases in rodents: Virus-based models versus inoculation of exogenous preformed toxic species. Journal of Neuroscience Methods. 2020;338:108685. doi: 10.1016/j.jneumeth.2020.108685
</cite> [<a href="https://doi.org/10.1016/j.jneumeth.2020.108685" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32173400/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neuroscience%20Methods&amp;title=Advances%20in%20modelling%20alpha-synuclein-induced%20Parkinson%E2%80%99s%20diseases%20in%20rodents:%20Virus-based%20models%20versus%20inoculation%20of%20exogenous%20preformed%20toxic%20species&amp;author=AR%20Carta&amp;author=L%20Boi&amp;author=A%20Pisanu&amp;author=MF%20Palmas&amp;author=E%20Carboni&amp;volume=338&amp;publication_year=2020&amp;pages=108685&amp;pmid=32173400&amp;doi=10.1016/j.jneumeth.2020.108685&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref016">
<span class="label">16.</span><cite>Janezic S, Threlfell S, Dodson PD, Dowie MJ, Taylor TN, Potgieter D, et al. Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proc Natl Acad Sci U S A. 2013;110(42):E4016-25. doi: 10.1073/pnas.1309143110

</cite> [<a href="https://doi.org/10.1073/pnas.1309143110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3801069/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24082145/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;title=Deficits%20in%20dopaminergic%20transmission%20precede%20neuron%20loss%20and%20dysfunction%20in%20a%20new%20Parkinson%20model&amp;author=S%20Janezic&amp;author=S%20Threlfell&amp;author=PD%20Dodson&amp;author=MJ%20Dowie&amp;author=TN%20Taylor&amp;volume=110&amp;issue=42&amp;publication_year=2013&amp;pmid=24082145&amp;doi=10.1073/pnas.1309143110&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref017">
<span class="label">17.</span><cite>Benzow K, Karanjeet K, Oblak AL, Carter GW, Sasner M, Koob MD. Gene replacement-Alzheimer’s disease (GR-AD): Modeling the genetics of human dementias in mice. Alzheimers Dement. 2024;20(4):3080–7. doi: 10.1002/alz.13730

</cite> [<a href="https://doi.org/10.1002/alz.13730" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11032548/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38343132/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alzheimers%20Dement&amp;title=Gene%20replacement-Alzheimer%E2%80%99s%20disease%20(GR-AD):%20Modeling%20the%20genetics%20of%20human%20dementias%20in%20mice&amp;author=K%20Benzow&amp;author=K%20Karanjeet&amp;author=AL%20Oblak&amp;author=GW%20Carter&amp;author=M%20Sasner&amp;volume=20&amp;issue=4&amp;publication_year=2024&amp;pages=3080-7&amp;pmid=38343132&amp;doi=10.1002/alz.13730&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref018">
<span class="label">18.</span><cite>Zhao C, Puurunen K, Schallert T, Sivenius J, Jolkkonen J. Effect of cholinergic medication, before and after focal photothrombotic ischemic cortical injury, on histological and functional outcome in aged and young adult rats. Behav Brain Res. 2005;156(1):85–94. doi: 10.1016/j.bbr.2004.05.011

</cite> [<a href="https://doi.org/10.1016/j.bbr.2004.05.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15474653/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Behav%20Brain%20Res&amp;title=Effect%20of%20cholinergic%20medication,%20before%20and%20after%20focal%20photothrombotic%20ischemic%20cortical%20injury,%20on%20histological%20and%20functional%20outcome%20in%20aged%20and%20young%20adult%20rats&amp;author=C%20Zhao&amp;author=K%20Puurunen&amp;author=T%20Schallert&amp;author=J%20Sivenius&amp;author=J%20Jolkkonen&amp;volume=156&amp;issue=1&amp;publication_year=2005&amp;pages=85-94&amp;pmid=15474653&amp;doi=10.1016/j.bbr.2004.05.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref019">
<span class="label">19.</span><cite>Heikkinen T, Bragge T, Bhattarai N, Parkkari T, Puoliväli J, Kontkanen O, et al. Rapid and robust patterns of spontaneous locomotor deficits in mouse models of Huntington’s disease. PLoS One. 2020;15(12):e0243052. doi: 10.1371/journal.pone.0243052

</cite> [<a href="https://doi.org/10.1371/journal.pone.0243052" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7769440/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33370315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Rapid%20and%20robust%20patterns%20of%20spontaneous%20locomotor%20deficits%20in%20mouse%20models%20of%20Huntington%E2%80%99s%20disease&amp;author=T%20Heikkinen&amp;author=T%20Bragge&amp;author=N%20Bhattarai&amp;author=T%20Parkkari&amp;author=J%20Puoliv%C3%A4li&amp;volume=15&amp;issue=12&amp;publication_year=2020&amp;pmid=33370315&amp;doi=10.1371/journal.pone.0243052&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref020">
<span class="label">20.</span><cite>Gundersen HJ. Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. Thompson. J Microsc. 1986;143(Pt 1):3–45. 
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/3761363/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Microsc&amp;title=Stereology%20of%20arbitrary%20particles.%20A%20review%20of%20unbiased%20number%20and%20size%20estimators%20and%20the%20presentation%20of%20some%20new%20ones,%20in%20memory%20of%20William%20R.%20Thompson&amp;author=HJ%20Gundersen&amp;volume=143&amp;publication_year=1986&amp;pages=3-45&amp;pmid=3761363&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref021">
<span class="label">21.</span><cite>Weihofen A, Liu Y, Arndt JW, Huy C, Quan C, Smith BA, et al. Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson’s disease models. Neurobiol Dis. 2019;124:276–88. doi: 10.1016/j.nbd.2018.10.016

</cite> [<a href="https://doi.org/10.1016/j.nbd.2018.10.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30381260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurobiol%20Dis&amp;title=Development%20of%20an%20aggregate-selective,%20human-derived%20%CE%B1-synuclein%20antibody%20BIIB054%20that%20ameliorates%20disease%20phenotypes%20in%20Parkinson%E2%80%99s%20disease%20models&amp;author=A%20Weihofen&amp;author=Y%20Liu&amp;author=JW%20Arndt&amp;author=C%20Huy&amp;author=C%20Quan&amp;volume=124&amp;publication_year=2019&amp;pages=276-88&amp;pmid=30381260&amp;doi=10.1016/j.nbd.2018.10.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref022">
<span class="label">22.</span><cite>Song P, Mabrouk OS, Hershey ND, Kennedy RT. In vivo neurochemical monitoring using benzoyl chloride derivatization and liquid chromatography-mass spectrometry. Anal Chem. 2012;84(1):412–9. doi: 10.1021/ac202794q

</cite> [<a href="https://doi.org/10.1021/ac202794q" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3259198/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22118158/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anal%20Chem&amp;title=In%20vivo%20neurochemical%20monitoring%20using%20benzoyl%20chloride%20derivatization%20and%20liquid%20chromatography-mass%20spectrometry&amp;author=P%20Song&amp;author=OS%20Mabrouk&amp;author=ND%20Hershey&amp;author=RT%20Kennedy&amp;volume=84&amp;issue=1&amp;publication_year=2012&amp;pages=412-9&amp;pmid=22118158&amp;doi=10.1021/ac202794q&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref023">
<span class="label">23.</span><cite>Skjærbæk C, Knudsen K, Horsager J, Borghammer P. Gastrointestinal Dysfunction in Parkinson’s Disease. J Clin Med. 2021;10(3):493. doi: 10.3390/jcm10030493

</cite> [<a href="https://doi.org/10.3390/jcm10030493" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7866791/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33572547/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Med&amp;title=Gastrointestinal%20Dysfunction%20in%20Parkinson%E2%80%99s%20Disease&amp;author=C%20Skj%C3%A6rb%C3%A6k&amp;author=K%20Knudsen&amp;author=J%20Horsager&amp;author=P%20Borghammer&amp;volume=10&amp;issue=3&amp;publication_year=2021&amp;pages=493&amp;pmid=33572547&amp;doi=10.3390/jcm10030493&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref024">
<span class="label">24.</span><cite>Stefani A, Högl B. Sleep in Parkinson’s disease. Neuropsychopharmacology. 2020;45(1):121–8. doi: 10.1038/s41386-019-0448-y

</cite> [<a href="https://doi.org/10.1038/s41386-019-0448-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6879568/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31234200/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;title=Sleep%20in%20Parkinson%E2%80%99s%20disease&amp;author=A%20Stefani&amp;author=B%20H%C3%B6gl&amp;volume=45&amp;issue=1&amp;publication_year=2020&amp;pages=121-8&amp;pmid=31234200&amp;doi=10.1038/s41386-019-0448-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref025">
<span class="label">25.</span><cite>Broen MPG, Narayen NE, Kuijf ML, Dissanayaka NNW, Leentjens AFG. Prevalence of anxiety in Parkinson’s disease: A systematic review and meta-analysis. Mov Disord. 2016;31(8):1125–33. doi: 10.1002/mds.26643

</cite> [<a href="https://doi.org/10.1002/mds.26643" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27125963/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mov%20Disord&amp;title=Prevalence%20of%20anxiety%20in%20Parkinson%E2%80%99s%20disease:%20A%20systematic%20review%20and%20meta-analysis&amp;author=MPG%20Broen&amp;author=NE%20Narayen&amp;author=ML%20Kuijf&amp;author=NNW%20Dissanayaka&amp;author=AFG%20Leentjens&amp;volume=31&amp;issue=8&amp;publication_year=2016&amp;pages=1125-33&amp;pmid=27125963&amp;doi=10.1002/mds.26643&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref026">
<span class="label">26.</span><cite>La-Vu M, Tobias BC, Schuette PJ, Adhikari A. To Approach or Avoid: An Introductory Overview of the Study of Anxiety Using Rodent Assays. Front Behav Neurosci. 2020;14. doi: 10.3389/fnbeh.2020.00145</cite> [<a href="https://doi.org/10.3389/fnbeh.2020.00145" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7479238/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33005134/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Behav%20Neurosci&amp;title=To%20Approach%20or%20Avoid:%20An%20Introductory%20Overview%20of%20the%20Study%20of%20Anxiety%20Using%20Rodent%20Assays&amp;author=M%20La-Vu&amp;author=BC%20Tobias&amp;author=PJ%20Schuette&amp;author=A%20Adhikari&amp;volume=14&amp;publication_year=2020&amp;pmid=33005134&amp;doi=10.3389/fnbeh.2020.00145&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref027">
<span class="label">27.</span><cite>Pang SY-Y, Ho PW-L, Liu H-F, Leung C-T, Li L, Chang EES, et al. The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease. Transl Neurodegener. 2019;8:23. doi: 10.1186/s40035-019-0165-9

</cite> [<a href="https://doi.org/10.1186/s40035-019-0165-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6696688/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31428316/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Transl%20Neurodegener&amp;title=The%20interplay%20of%20aging,%20genetics%20and%20environmental%20factors%20in%20the%20pathogenesis%20of%20Parkinson%E2%80%99s%20disease&amp;author=SY-Y%20Pang&amp;author=PW-L%20Ho&amp;author=H-F%20Liu&amp;author=C-T%20Leung&amp;author=L%20Li&amp;volume=8&amp;publication_year=2019&amp;pages=23&amp;pmid=31428316&amp;doi=10.1186/s40035-019-0165-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref028">
<span class="label">28.</span><cite>Ma J, Gao J, Wang J, Xie A. Prion-Like Mechanisms in Parkinson’s Disease. Front Neurosci. 2019;13:552. doi: 10.3389/fnins.2019.00552

</cite> [<a href="https://doi.org/10.3389/fnins.2019.00552" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6591488/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31275093/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Neurosci&amp;title=Prion-Like%20Mechanisms%20in%20Parkinson%E2%80%99s%20Disease&amp;author=J%20Ma&amp;author=J%20Gao&amp;author=J%20Wang&amp;author=A%20Xie&amp;volume=13&amp;publication_year=2019&amp;pages=552&amp;pmid=31275093&amp;doi=10.3389/fnins.2019.00552&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329823.ref029">
<span class="label">29.</span><cite>Sokratian A, Zhou Y, Tatli M, Burbidge KJ, Xu E, Viverette E, et al. Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases. Sci Adv. 2024;10(44):eadq3539. doi: 10.1126/sciadv.adq3539

</cite> [<a href="https://doi.org/10.1126/sciadv.adq3539" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11800946/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39485845/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Adv&amp;title=Mouse%20%CE%B1-synuclein%20fibrils%20are%20structurally%20and%20functionally%20distinct%20from%20human%20fibrils%20associated%20with%20Lewy%20body%20diseases&amp;author=A%20Sokratian&amp;author=Y%20Zhou&amp;author=M%20Tatli&amp;author=KJ%20Burbidge&amp;author=E%20Xu&amp;volume=10&amp;issue=44&amp;publication_year=2024&amp;pmid=39485845&amp;doi=10.1126/sciadv.adq3539&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>S1 Fig. CRISPR editing design and resulting sequence of the aSyn A53T KI rat.</span><p>Editing design and humanized sequence in the aSyn A53T KI rat. (A) Visual schematic of the editing design depicting homology arm left (HAL), the targeted exon 4 region and replacement with partial human <em>SNCA</em> cDNA, the BGHpA-SV40pA, and the homology arm right (HAR). (B) Sequence alignment comparing the rat aSyn, human aSyn, and the sequence of the human aSyn cDNA incorporated into the model. Yellow highlight indicates the endogenous threonine at amino acid 53 in rat aSyn which was maintained in the aSyn A53T KI line. Pink highlights indicate amino acid differences between rat and human aSyn. Green highlight indicates the amino acids that were altered in rat aSyn through the incorporation of the partial human cDNA. (C) DNA sequencing of donor DNA used for the CRISPR edit, indicating homology arms in black, partial human SNCA cDNA sequence in blue, and BGHpA-SV40pA in orange.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334032/bin/pone.0329823.s001.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0329823.s001.tif</a><sup> (1.1MB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p">
<span>S2 Fig. Positive control tissue for pathological marker immunostaining.</span><p>(A) Representative images of staining for pS202/T205 tau in the cortex of P301S tau transgenic mice. (B) Representative images of staining for pS129 aSyn in the SNpc of LRRK2 G2019S KI mice injected with adeno-associated virus to overexpress human A53T aSyn.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334032/bin/pone.0329823.s002.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0329823.s002.tif</a><sup> (688.4KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p">
<span>S3 Fig. Uncropped western blot images corresponding to Fig 3.</span><p>Uncropped and unadjusted western blot image of (A) total aSyn and actin control in aSyn KO and WT littermate rats, (B) total aSyn, triton-soluble aSyn, triton-insoluble aSyn and actin control in aSyn A53T KI and WT littermate rats.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334032/bin/pone.0329823.s003.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0329823.s003.tif</a><sup> (622KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="caption p">
<span>S4 Fig. Gait characteristics and fine motor skills during walking in female aSyn A53T KI and WT rats.</span><p>Principal component scores generated by the principal component analysis of analysis of different gait patterns and movements. Movement of different body points in relation to the ground and their correlation in the three spatial dimensions was examined. Data are presented as the mean ± standard error of the mean. Statistical significance of differences is illustrated as follows: <sup>#</sup><em>P</em> &lt; 0.05; <sup>##</sup><em>P</em> &lt; 0.01 (Student’s <em>t</em>-test). The Correlation heat map depicts the degree of correlation for each walking parameter in the whole data set. Red color means positive correlation and blue means negative correlation. Number in the X-axis represents corresponding PC number.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334032/bin/pone.0329823.s004.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0329823.s004.tif</a><sup> (317.7KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="caption p">
<span>S5 Fig. Gait characteristics and fine motor skills during walking in male aSyn A53T KI and WT rats.</span><p>Principal component scores generated by the principal component analysis of analysis of different gait patterns and movements. Movement of different body points in relation to the ground and their correlation in the three spatial dimensions was examined. Data are presented as the mean ± standard error of the mean. Statistical significance of differences is illustrated as follows: <sup>#</sup><em>P</em> &lt; 0.05; <sup>##</sup><em>P</em> &lt; 0.01 (Student’s <em>t</em>-test). The Correlation heat map depicts the degree of correlation for each walking parameter in the whole data set. Red color means positive correlation and blue means negative correlation. Number in the X-axis represents corresponding PC number.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12334032/bin/pone.0329823.s005.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0329823.s005.tif</a><sup> (260.5KB, tif) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data underlying the results presented in the study are available from the MJFF Data Repository on Zenodo at <a href="https://doi.org/10.5281/zenodo.16109481" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.5281/zenodo.16109481</a>.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from PLOS One are provided here courtesy of <strong>PLOS</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1371/journal.pone.0329823"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/pone.0329823.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.7 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12334032/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12334032/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12334032%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334032/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12334032/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12334032/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40779487/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12334032/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40779487/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12334032/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12334032/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="PDLssI9CETYR5SKGWi4ZiklVYjECdoG3K8hXcoc7qsnfJZZCOpdhCeP0tCiwkHKV">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
